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Adverse early-life experiences, such as poormaternal care, program an abnormal stress response thatmay involve an altered balance between
excitatory and inhibitory signals.Here,we exploredhowearly-life stress (ELS) affects excitatory and inhibitory transmission in corticotrophin-
releasing factor (CRF)-expressing dorsal-medial (mpd) neurons of the neonatal mouse hypothalamus. We report that ELS associates with
enhanced excitatory glutamatergic transmission that is manifested as an increased frequency of synaptic events and increased extrasynaptic
conductance,with the latterassociatedwithdysfunctionalastrocytic regulationofglutamate levels.Theneurosteroid5-pregnan-3-ol-20-one
(53-THPROG) is an endogenous, positivemodulator of GABAA receptors (GABAARs) that is abundant during brain development and rises
rapidlyduringacute stress, therebyenhancing inhibition to curtail stress-inducedactivationof thehypothalamic-pituitary-adrenocortical axis.
In control mpd neurons, 53-THPROG potently suppressed neuronal discharge, but this action was greatly compromised by prior ELS
exposure. This neurosteroid insensitivity did not primarily result from perturbations of GABAergic inhibition, but rather arose functionally
fromthe increasedexcitatorydriveontompdneurons.Previousreports indicated thatmice (dams) lacking theGABAAR subunit (
0/0) exhibit
alteredmaternalbehavior. Intriguingly,0/0 offspringshowedsomehallmarksofabnormalmaternal care thatwere furtherexacerbatedbyELS.
Moreover, in common with ELS, mpd neurons of 0/0 pups exhibited increased synaptic and extrasynaptic glutamatergic transmission and
consequently a blunted neurosteroid suppression of neuronal firing. This study reveals that increased synaptic and tonic glutamatergic trans-
mission may be a common maladaptation to ELS, leading to enhanced excitation of CRF-releasing neurons, and identifies neurosteroids as
putative early regulators of the stress neurocircuitry.
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Introduction
Stressful experiences engage a coordinated neuronal and
hormonal response that is orchestrated by the hypothalamic-
pituitary-adrenocortical (HPA) axis via activation of corti-
cotrophin-releasing factor (CRF)-releasing parvocellular
neurons of the hypothalamic paraventricular nucleus (PVN; de
Kloet et al., 2005; Joe¨ls and Baram, 2009; Ulrich-Lai andHerman,
2009). Dysfunction of this fundamental survival mechanism is
programmed early in life (Bale et al., 2010) and abnormal regu-
lation, for example, as a consequence of adverse early-life experi-
ences, is crucially implicated in various psychiatric disorders
including depression (Lupien et al., 2009; Baram et al., 2012;
Franklin et al., 2012). Interestingly, perturbations in glutamater-
gic transmission have been linked to depression in both clinical
and animal studies (Popoli et al., 2012; Sanacora et al., 2012).
Analysis of molecular markers of glutamatergic transmission
suggests that similar adaptations may also underpin HPA axis
dysfunction (Flak et al., 2009). Here, we used a mouse model of
early-life stress (ELS; Rice et al., 2008) to investigate how negative
early-life experiences may affect neurotransmitter function in
CRF-expressing (CRFve) dorsal-medial (mpd) neurons of the
mouse hypothalamus. In a combined electrophysiological and
immunohistochemical approach, we show that ELS associates
primarily with a significant increase in the excitatory drive
(mediated by synaptic and extrasynaptic ionotropic glutamate
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receptors) onto mpd neurons. Certain endogenously occurring
neurosteroids (e.g., 5-pregnan-3-ol-20-one [53-THPROG])
abundant early in development (Grobin and Morrow, 2001) po-
tently and selectively enhanceGABAA receptor (GABAAR) function
at low nanomolar concentrations (Belelli and Lambert, 2005). In-
triguingly, neurosteroid levels change dynamically in response to a
variety of stimuli, such as after an acute stress challenge (Purdy et al.,
1991; Barbaccia et al., 1996; Biggio et al., 2007), suggesting that they
may “fine-tune” GABAAR inhibitory function in the PVN (Decavel
and Van den Pol, 1990; Boudaba et al., 1996; Miklo´s and Kova´cs,
2002, 2012; Di et al., 2005; Verkuyl et al., 2005; Cullinan et al., 2008;
Hewitt et al., 2009; Popescu et al., 2010;Wamsteeker et al., 2010) to
influenceHPAaxis activity (Patchev et al., 1994).Here,we show that
ELS blunts the potent inhibitory actions of 53-THPROG upon
the neuronal discharge of CRFve mpd neurons of the neonatal
mousehypothalamus.The loss of neurosteroid efficacy is not caused
byachange inGABAergic inhibition,butprimarilyby the significant
increase in theexcitatorydriveontompdneurons,which is sufficient
to functionallyovercome the suppressant actionof theneurosteroid.
Dams lacking the GABAAR -subunit exhibit a depressive pheno-
type and altered maternal behavior (Maguire andMody, 2008). In-
triguingly, we find that the offspring of mice lacking the GABAAR
-subunit (0/0) present hallmarks of an abnormal stress response
and, importantly, share with ELS mice an increased glutamatergic
drive with an associated loss of neurosteroid inhibition. Therefore,
this neuronal plasticity may be a common maladaptation of the
hypothalamic stress centers to negative early-life experiences. These
results provide compelling support for glutamate receptors as an
innovative avenue of therapeutic intervention for stress-related pa-
thologies suchasdepressionand raise the excitingprospect thatneu-
rosteroidsmay be an importantmolecular signal for thematuration
of the HPA axis.
Materials andMethods
Breeding of mice
The  0/0 mice and wild-type (WT) controls were generated on a C57BL/
6J-129SvSvJ background at the University of Pittsburgh and bred at the
University ofDundee as described previously (Mihalek et al., 1999).Mice
were group housed, given free access to standard rodent chow and water,
and maintained on a 12 h alternating light-dark cycle with lights on at
07:30.
ELS paradigm
The ELS paradigm was adapted from Rice et al. (2008). Specifically,
pregnant damswere housed singly andmonitored every 12 h for the birth
of pups. The day of birth was termed postnatal day 0 (P0) and both the
control and ELS dams were left undisturbed until P2. On P2, litters were
adjusted to a maximum of eight pups of both sexes. Control dams were
housed in standard sawdust bedding and providedwith sufficient nesting
material (1 square; DBM Scotland). In the ELS cages, dams were pro-
videdwith reduced bedding (2/3 square) placed upon a raised, fine-gauge
(5 mm) steel mesh platform. The cage floor was covered with a small
amount of sawdust to prevent ammonia buildup. All litters were left
undisturbed between P2 and P9. On P9, both control and ELS pups were
weighed before being returned, with dams, to “control” cages (i.e., with
standard bedding and nesting material). Offspring then remained with
the dams until weaning at P24.
Assessment and analysis of maternal behavior
The maternal behavior of control (n  7) and ELS (n  7) dams was
initially evaluated on day of life 3–8 of the pups to validate the previously
described model. Briefly, control and ELS dams were observed (by video
camera) three times a day during the light (08:30, 15:00) and dark (20:00)
phases for 30 min sessions with minimum disturbance to the mice (the
experimenter left the roomduring the recording session).During each 30
min observation period, the number of sorties that the dam made from
the nest (i.e., no contact with pups) was recorded. The dam–pup inter-
action was scored every other minute (resulting in 15  1 min epochs)
and the position of the dam with regard to the nest (i.e., inside nest,
outside nest, or a mixture of both) was recorded for the entire 1 min
epoch. The same parameters were used to evaluate thematernal behavior
of dams lacking the -GABAAR both in control breeding conditions (n
5) and after ELS (n  5). The number of sorties and the duration of
dam–pup interaction was analyzed for each observation period and a
total for both parameters was calculated for every treatment day and
averaged across litters. A two-way ANOVA was applied to assess the
correlation between treatment group and each postpartum day. Statisti-
cal comparisons between the total number of sorties of different treat-
ment groups were made using the unpaired Student’s t test.
Electrophysiology
Slice preparation
WT control, WT ELS, and  0/0 mice of either sex (P18–P26) were killed
by cervical dislocation in accordance with Schedule I of the UK Govern-
ment Animals (Scientific Procedures) Act of 1986. Coronal hypotha-
lamic slices containing the PVN were prepared as described previously
(Zaki and Barrett-Jolley, 2002). The brain was rapidly dissected and
placed in ice-cold (0–4°C), oxygenated (95% O2) artificial CSF (aCSF)
containing the following (in mM): 135 NaCl, 2.5 KCl, 1.25 NaH2PO4, 10
MgCl2, 0.5 CaCl2, 26 NaHCO3, and 10 glucose, 320–335 mOsm, pH
7.4. Coronal hypothalamic slices were then cut (300–320 m) using a
Vibratome (Leica) at 0–4°C. Slices were subsequently incubated for at
least 1 h at room temperature in a holding chamber containing oxygen-
ated aCSF (as above, but also containing 1 mM ascorbic acid and 3 mM
sodium pyruvate) before being transferred to the recording chamber.
Recordings were performed on slices perfused (3–6 ml/min) with extra-
cellular solution (ECS) containing the following (in mM): 126 NaCl, 26
NaHCO3, 2.95 KCl, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, and 10 glucose,
306–309 mOsm, pH7.4.
Recordings
All recordings were performed using an Axopatch 1D amplifier (Molec-
ular Devices) stored directly to a PC using a NI-DAQmx interface (Na-
tional Instruments) for analysis offline.
Characterization of parvocellular neurons, current-clamp recordings.
Parvocellular neurons were identified based upon a combination of im-
munohistochemical, anatomical, and morphological criteria described
previously in rats (Luther et al., 2002; Verkuyl and Joe¨ls, 2003) using an
Olympus BX50 microscope equipped with IR/DIC optics. For parvocel-
lular neurons, the expression of aCa2-dependent low threshold current
(LTS) was assessed with a current–clamp protocol as described previ-
ously (Luther et al., 2002). Briefly, the input resistance of individual
neuronswas calculated after a hyperpolarizing current injection of 20–30
pA for a duration of 400 ms. Cells were then tested with a 400 ms hyper-
polarizing current injection that lowered themembrane potential of neu-
rons to between 90 and 110 mV, to de-inactivate resident low
threshold Ca2 channels. The size of the current injection was calculated
for individual mpd neurons based upon the input resistance of each
neuron using Ohms law (I V/R). For these recordings, patch pipettes
with a resistance of 4–6 M were pulled from thick-wall borosilicate
glass (1.55 mm outer diameter; 0.95 mm inner diameter; Garner Glass)
and filledwith an intracellular solution containing the following (inmM):
130 K-gluconate, 10 HEPES, 10 EGTA, 1 NaCl, 1 MgCl2, 1 CaCl2, 2
Mg-ATP, and 0.5 Na-GTP, pH 7.2 with KOH. The osmolarity of the
intracellular solution was adjusted to 300–310 mOsm with D-mannitol.
A measured liquid junction potential of 11 mV was corrected as de-
scribed previously (Neher, 1992).
Using such an approach, recordings were made from the mid-
rostrocaudal level of the PVN, an area that has a high density of CRFve
parvocellular neurons (Biag et al., 2012). We found that, in common
with the rat (Luther et al., 2002) low threshold Ca2 spikes (LTS) were
absent in the majority (90%) of mpd neurons of the mouse PVN,
whereas neurons located in dorsal and ventral medial parvocellular re-
gions (dp and mpv neurons, respectively) exhibited a prominent LTS
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(Fig. 2A). Furthermore, post hoc immunohistochemical analysis of
biocytin-filled cells (5–10min recording) confirmed that neurons within
the mpd region expressed CRF (see Immunohistochemistry; Visualiza-
tion of biocytin filled neurons and Fig. 2B). The observedCRF expression
is in agreement with the recent immunocytochemical analysis in a
C57BL/6J mouse line indicating that CRFve parvocellular neurons are
concentrated in the dorsal-medial parvocellular region (Alon et al.,
2009).
Action currents. Cell-attached recordings of spontaneous truncated
action currents were made at 30–32°C in ECS as per Zaki and Barrett-
Jolley (2002). Patch pipettes with a resistance of 4–6Mwere filled with
an intracellular solution containing the following (in mM); 130
K-gluconate, 10 HEPES, 10 EGTA, 1 CaCl2 and 1 MgCl2, pH 7.2 with
KOH. A seal was obtained (50 M) and the action current frequency
allowed to stabilize for at least 10 min before recording, although a qual-
itative assessment of the tonic versus bursting nature of the firing (see
Data analysis; Action currents) could be made after 5 min of recording.
Action currents were recorded in the voltage-clamp configuration at a
holding potential thatmaintained a 0 pA leak current (Perkins, 2006) and
filtered at 5 kHz using an 8-pole low-pass Bessel filter.
Recordings of mIPSCs, sIPSCs, mEPSCs, and sEPSCs. Whole-cell
voltage-clamp recordings of mIPSCs were obtained from mpd neurons
at 35°C in ECS containing 2 mM kynurenic acid (Sigma Chemicals) and
0.5MTTX (Tocris Bioscience) to block ionotropic glutamatergic trans-
mission and action potentials, respectively. Patch pipettes with a resis-
tance of 4–6Mwere filled with an intracellular solution containing the
following (in mM); 135 CsCl, 10 HEPES, 10 EGTA, 1 MgCl2, 1 CaCl2, 2
Mg-ATP, and 5 QX-314 (Alamone Labs), 290–300 mOsm, pH 7.2–7.3
with CsOH.mIPSCs were recorded at a holding potential of60mV. In
a subset of experiments, sEPSCs/sIPSCs and mEPSCs/mIPSCs were re-
corded from the same mpd neuron at 35°C in ECS in the absence and
presence of TTX, respectively, using a low Cl (12 mM) intracellular
solution. In these recordings, patch pipettes were filled with an intracel-
lular solution containing the following (in mM): 135 CH3O3SCs, 8 CsCl,
10HEPES, 10 EGTA, 1MgCl2, 1CaCl2, 300–310mOsm, pH7.2–7.3with
CsOH. Under such recording conditions, the calculated (pClamp Ver-
sion 8.2) and experimentally verified EGABA and EGlutamate were63 and
0 mV, respectively. Therefore, EPSCs and IPSCs (miniature and sponta-
neous) were recorded at a holding potential of 63 and 0 mV, respec-
tively. In both sets of experiments, currents were filtered at 2 kHz using
an 8-pole low-pass Bessel filter. The series resistance was between 8 and
20 M with up to 80% compensation. Only cells with a stable access
resistance were used and experiments were aborted for series resistance
changes 20%.
Recording of tonic GABA and glutamate currents. Whole-cell voltage-
clamp recordings to determine the presence of tonic GABA (IGABA) and
glutamate (IGlutamate) currents in mpd neurons were made at 35°C in
normal or low Mg2 (0.5 mM) ECS, respectively, also containing the
nonselective ionotropic glutamate antagonist kynurenic acid (2 mM) or
the GABAAR antagonist bicuculline (30 M), respectively. For IGABA
measurements, recordings were made at a holding potential of60 mV
with an intracellular solution containing the following (in mM): 135
CsCl, 10 HEPES, 10 EGTA, 1 MgCl2, 1 CaCl2, 2 Mg-ATP and 5 QX-314,
290–300 mOsm, pH 7.2–7.3 with CsOH. For IGlutamate measurements,
recordings were made at a holding potential of 40 mV with an intra-
cellular solution containing the following (in mM): 135 CH3O3SCs, 1
EGTA, 10HEPES, 5 TEA-Cl, 1MgCl, 0.5 Na-GTP, 2Mg-ATP, and 5 Tris
phosphocreatine, 280–290 mOsm, pH 7.2–7.3 with CsOH. Bicuculline
(30 M) and kynurenic acid (2 mM) were used to define IGABA and
IGlutamate, respectively.
Perforated patch recording. Perforated patch recordings were made
frommpdneurons at 28–30°C (tominimize the likelihood ofmembrane
rupture and whole-cell configuration) in ECS additionally containing 1
M CGP53432 to block metabotropic GABAB receptors. Patch pipettes
with a resistance of 4–6Mwere tip filled with a prefiltered intracellular
solution containing the following (in mM): 130 KCl, 10 HEPES, 0.1
EGTA, 1 MgCl2, 0.1 CaCl2, pH 7.2 with KOH, and then back-filled with
the same solution also containing 75 g ml1 gramicidin (diluted from
a fresh 75 mg ml1 stock solution in DMSO). The gramicidin-
containing pipette solution was sonicated for 10 min before
experimentation and continually vortexed gently throughout the exper-
imentation period. Because of precipitation of the antibiotic at this high
concentration, the intracellular solution was prepared fresh every 2–3 h.
Upon acquisition of a high-resistance seal (1 G), the progress of
perforation was monitored in voltage-clamp mode (holding potential
60 mV) by observing the slow development (typically 	45 min) of
capacitance transients in response to5 mV hyperpolarizing steps. The
high Cl concentration of the pipette solution ensured that undesired
membrane rupture could be monitored as a sudden increase in the am-
plitude of the capacitance transients and the subsequent appearance of
inwardly directed GABAergic synaptic currents. Such recordings were
immediately discarded.Once fully perforated (	60M), a current ( I)
voltage (V) plot was generated to estimate the EGABA of the recorded cell.
Briefly, the recorded cell was held at holding potentials ranging from50
to 90 mV and GABA (1 mM in pipette) was locally applied from a
second patch pipette (situated30–40m from cell) to the cell soma by
pressure injection (10ms duration, 2–5 psi) using a Picospritzer II system
(Intracel). At each holding potential, the response to GABA was mea-
sured from a minimum of three consecutive applications presented at
10 s intervals to prevent GABAAR desensitization. Throughout the
recording, the GABA response at a holding potential of 60 mV was
assessed continually (i.e., after each change of holding potential) to en-
sure that the perforated patch had not ruptured or the perforation had
not improved. The liquid junction potential, estimated to be 3.4 mV
(using pClamp Version 8.2), was left uncorrected. The recording config-
uration was switched to the current-clamp mode to confirm the EGABA
measured under voltage-clamp conditions and to measure the resting
membrane potential (VMembrane). Note that TTX (0.5 M) was bath ap-
plied to spontaneously firing neurons and the VMembrane measured im-
mediately after cessation of action potential firing. The voltage drop
arising from the series resistance was corrected using the simulated
bridge balance circuitry of the amplifier. All GABA-induced currents
were filtered at 5 kHz using an 8-pole low-pass Bessel filter.
Data analysis
All recordings were analyzed offline using the Strathclyde Electrophysi-
ology Software (Electrophysiology Data Recorder [WinEDR] andWhole
Cell analysis Program [WinWCP]; courtesy of Dr J. Dempster, Univer-
sity of Strathclyde).
Whole-cell current-clamp recordings
Using WinEDR, the presence or absence of an LTS after the application
of a hyperpolarizing current injectionwas confirmed by the inspection of
individual recordings. The input resistance of mpd neurons was calcu-
lated offline using Ohm’s law (RInput  VMembrane/IInject). The mean
input resistance was calculated from three to five current injections/cell.
Current pulses were rejected if a steady plateau phase was not reached or
if the charging of the cell membrane was contaminated by truncated
action potentials.
Action currents
Using WinEDR, events were detected (offline) using a method based on
a rate of rise threshold (60–120 pA/ms) that was specific for individual
cells. Any electrical noise detected as an event was removed and any
undetected action currents were included after a manual inspection. Fir-
ing frequency and interevent interval (IEI) were calculated using
WinEDR. In commonwith the rat, the firing of mousempd neurons was
heterogeneous, displaying “burst-like” or “tonic” patterns of firing. To
determine and quantify the steroid effect reliably, the action of 53-
THPROGwas restricted to “tonically” firing cells. Cells with a coefficient
of variation (calculated as the ratio of the SD of the IEI to the mean IEI)
of 0.5 were deemed to display tonic firing (21% of all cells; Yang et al.,
2007). A mean frequency and IEI before and after drug application was
calculated for aminimumof 6min of recording time using 90 s bins (i.e.,
4 bins) for each experimental condition. In experiments investigating
the actions of 53-THPROG and 4,5,6,7-tetrahydroisoxazolo[4,5-
c]pyridin-3-ol (THIP), a minimum perfusion period of 10 and 4 min,
respectively, were allowed before the drug effect upon the action current
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frequency was assessed. Note that THIP required a reduced perfusion
time due to the more rapid onset of action compared with 53-
THPROG as assessed in voltage-clamp experiments of THIP-sensitive
neurons (e.g., thalamic ventrobasalis neurons; Belelli et al., 2005). To
allow a meaningful quantitative comparison across experiments, data
were normalized to the control frequency. The effects of 53-THPROG
and THIP upon the spontaneous firing were quantified after 10 and 4
min of bath application, respectively. Specifically, for every cell, the per-
centage change in action current firing relative to a 6min control section
was calculated for each 90 s bin throughout the recording. For each cell,
sensitivity to drug action was determined by comparing the percentage
change of 4 90 s bins (i.e., 6min) under control conditions and after drug
application. For each drug treatment, a mean percentage change in ac-
tion current firing was then calculated and statistically analyzed.
Voltage-clamp recordings: analysis of synaptic currents
Individual events were detected in WinEDR using an amplitude thresh-
old detection algorithm (4 pA threshold, 3 ms duration) and visually
inspected for validity (e.g., any noise that reached the threshold or traces
that contained multiple events were rejected). Accepted events (a mini-
mum of 40 for each experimental condition) were digitally averaged.
mIPSCs were analyzed with regard to peak amplitude, rise time, and
decay kinetics (T70% values, the time taken for the amplitude of each
event to decay to 70% of peak). Events with rise times 0.7 ms (repre-
senting 	1% of total) were discarded to eliminate from the analysis
events subject to dendritic filtering. The decay phase of the digitally
averaged event was then fitted with single exponential, [Y(t) 
A*exp(t/)], and biexponential functions, [Y(t)  A1*exp(t/1)
A2*exp(t/2)]. An F test was then used to establish whether the decay
was best described by a mono- or biexponential fit, as indicated by a
decrease in the SDof the residuals. Because all resultant averagedmIPSCs
were best described by a biexponential equation, a mean weighted decay
constant (w) was then calculated to describe the relative contribution
of each decay component according to the following equation: w 
[A
1
/(A1 A2)]*1 [A2/(A1 A2)]*2, where A1 and A2 describe the
relative contribution that 1 and 2 make to the overall decay time
course, respectively.
The frequency of mIPSCs, sIPSCs, and sEPSCs was determined for
each cell in the absence and presence of drug (e.g., 53-THPROG and
THIP) by counting the number of events in 20 s bins over a minimum of
2 separate 1 min periods (first and last minute) of a 5 min control and
drug section. Events were detected (offline) in WinEDR using a method
based on a rate of rise time threshold that was specific for individual cells
and that allows detection of the slowest events (40 pA/ms). Recordings
were then visually inspected to ensure that all events were included and
any detected spurious noise removed. A mean frequency and IEI was
then calculated. The sensitivity of each IPSC/EPSC parameter to a drug
action was determined for each neuron by comparing their cumulative
distribution before and after drug treatment with the Kolmogorov–
Smirnov (KS) test (see Statistical analysis).
Analysis of the tonic and drug-evoked current
The GABAergic and glutamatergic tonic current and the drug-induced
current were calculated as the difference in the mean baseline current
before and after application of bicuculline (30M IGABA), kynurenic acid
(2 mM IGlutamate) or the drug, respectively. The holding current and root
mean square (RMS; i.e., SD) were sampled every 102.4 ms (bicuculline
and THIP) or 51.2ms (AP-5 and kynurenic acid) over a 1min period for
Figure1. Maternal and CRF expression profile inWT and ELSmice.A, Graph summarizing themean number of sorties from the nest for control (CTRL: black, n 7) and ELS (red, n 7)WTdams
from P3–P8. A significant difference in the number of maternal sorties was observed between the two treatment groups (F(1,52) 10.9, p	 0.01), whereas the treatment day had no significant
effect (F(5,52) 1.01, p 0.42). B, Graph summarizing the mean dam–pup interaction time over P3–P8 for the same litters as above. There was no effect of day (F(5,52) 0.26, p 0.93) or
treatment (F(1,52) 1.04, p 0.31) upon the time spent in the nest (two-wayANOVA). C, Bar graphs summarizing themeanweights of CTRL (black) and ELS (red)WT at P9, P18–P24, and 8weeks
of age (CTRL, n 36–42; ELS, n 35–63. D, Representative images of CRF expression in the neonatal (P22–P28) PVN of CTRL and ELSWTmice. Note upregulation of somatic CRF expression in
the PVN of neonatal ELS WT mice. Tissue sections were reacted and imaged under identical conditions. D1, D3, HuC (a pan-neuronal marker) was used at all times to confirm that the regions
investigated are comparable.D2, CRF immunoreactivity within CTRLWT tissue is expressedwithin isolated somata and varicose processes.D4, In contrast, somatic CRF immunoreactivity is evident
to a greater extent throughout the PVN of ELSWT tissue. CRF immunoreactivity in ELS tissuewas significantly greater than that detected in CTRL tissue ( p	 0.001, unpaired Student’s t test). Scale
bars, 100m. Furthermore, this observed increase in CRF expression was maintained through to adulthood ( 2 months; see Results).
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Figure 2. Exposure to ELS greatly increases synaptic glutamatergic drive onto neonatalmpd neurons.A, Schematic representation of themouse PVN highlighting the anatomical organization of
magno- and parvocellular neurons and representative Iclamp recordingsmade fromputative preautonomic (dp) and neuroendocrine (mpd) neurons based upon their anatomical locationwithin the
PVN. Note that, in agreementwith studies in rats (Luther et al., 2002), putative preautonomic dp neurons expressed a prominent low-threshold Ca 2 spike, whereas putative neuroendocrinempd
cells did not. Scale bars: y 20mV, x 250ms. The highlighted region (red) in thempd region corresponds to the area where electrophysiological recordings were conducted.B, Confirmation of
the location and neurochemical profile of the recorded neurons. Top, Representative image providing an overviewof labeling for CRF (red) in a coronalmouse brain slice containing the PVN showing
the location of two recorded neurons (in green), which were filled with biocytin during the recordings. Bottom, High-resolution image of one of the recorded neurons with immunoreactivity for
biocytin and CRF pseudocolored blue and red, respectively. Scale bars: Top, 100m; bottom, 5m. C, Illustrated are sections (5 s) ofwhole-cell voltage-clamp recordings of sIPSCs (top) and sEPSCs
(bottom) recorded from the same representativempd neuron derived from a CTRL (left) and ELS (right)WTmouse. A section (shaded area, 0.5 s) of the recordings is displayed on an expanded time
scale below. Scale bars: IPSCs, y 20pA, EPSCs y 10pA, x 500ms and50ms for top andbottom traces, respectively. Bar graphs illustrate themean frequency of sIPSCs andmIPSCs (n 9–25;
D) and sEPSCs and mEPSCs (n 14–32; E) recorded from mpd neurons derived from CTRL (black) and ELS (red) WT mice. *p	 0.05; **p	 0.01 CTRL vs ELS, unpaired Student’s t test. F,
Representative images demonstrating the upregulation of vGLUT2 expression in the PVN of ELS compared with CTRL WT neonatal (P22–P28) mice. F1, F5, HuC, a (Figure legend continues.)
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each recording condition. At the sampling rate of 10 kHz, 1024 baseline
points for each 102.4 ms and 512 baseline points for each 51.2 ms pro-
vided one data point, respectively. Epochs containing synaptic events or
an unstable baseline were excluded from the analysis. Aminimumof 100
data points were measured for each recording condition (i.e., in the
absence and presence of drug). To ensure that a drug effect was genuine
and not simply due to a temporal “drift” in the holding current, two
separate 1 min sections of the holding current were analyzed during the
control period (C1 and C2). Similarly, a 1 min section was analyzed after
drug application (D) once the drug effect had reached a plateau. Similar
temporal intervals were selected between C1 and C2 and C2 and D to
control for temporally comparable drift during the control period and
after drug application. Themean DC values for each epoch of C1 and C2
were pooled and the SD calculated. A drug effect was considered genuine
if the absolute value of change in the holding current (i.e., D C2) was
greater than twice the SD associated with the DC measurements of the
control period.
Perforated patch recordings; determination of EGABA and
VMembrane
Current injections were manually detected offline using WinEDR and
the input resistance of cells calculated in a manner similar to that de-
scribed above using WinWCP. At each holding potential tested (cell
specific), the GABA-induced currents after local pressure application
were manually detected in WinEDR and events exported to WinWCP,
where the peak amplitude was measured. For each holding potential, the
average amplitude of a minimum of three GABA-evoked currents was
calculated. For each cell, the GABA-induced currents were normalized to
the holding potential at which the maximum current amplitude was
measured to permit a direct comparison of the I–V plots for CTRL WT,
ELSWT, and  0/0 neurons. The reversal potential of the GABA response
was calculated from the x-axis intercept of the current (x-axis)–voltage
( y-axis) relationship for each neuron. Epochs containing action poten-
tials or an unstable baselinewere excluded from the analysis. Aminimum
of 100 data points were measured for each cell. To calculate the resting
membrane potential (VMembrane), it was sampled every 102.4 ms over a
stable 1 min recording period. At the sampling rate of 10 kHz, 1024
baseline points for each 102.4 ms provided one data point. The GABA
driving force was calculated as the difference between the resting
VMembrane and the EGABA for each cell.
Reagents and drugs
All reagents were obtained from either Sigma or Tocris Bioscience unless
stated otherwise. Stock solutions of the neurosteroid 53-THPROG (a
generous gift from Dr K. Gee, University of California–Irvine) and
CGP54432 and TFB-TBOA (both Tocris Bioscience) were prepared as a
concentrated stock (1000) in DMSO and then diluted to the required
concentration in extracellular solution. The maximum vehicle concen-
tration (0.1%) had no effect upon receptor function. Stock solutions of
bicuculline (Alexis Biochemicals); D-AP-5, RO256981, and kynurenic
acid (all Ascent Scientific); tetrodotoxin (Tocris Bioscience); and the
-preferring agent THIP (a generous gift from Bjarke Ebert, K. Lund-
beck, Copenhagen Valby, Denmark) were prepared similarly as concen-
trated stock solutions (1000) in distilled water and then diluted to the
necessary concentration in the perfusion system. 53-THPROG was
applied to the brain slice via the perfusion system (3–6 ml/min) and
allowed to infiltrate the slice for a minimum of 10 min before recordings
were acquired; THIP and TFB-TBOAwere perfused for a shorter time of
at least 4 min.
Statistical analysis
All data are presented as the arithmetic mean
 SEM unless stated oth-
erwise. Statistical comparisons were made using Student’s t test (paired
and unpaired) and regular and repeated-measures ANOVA (one- and
two-way), followed by the post hoc Newman–Keuls test, as appropriate;
the KS test was used to compare populations of individual events before
and after drug application to a given cell using a stringent criterion for
significance (p 	 0.01). When normalized data are presented, mean
values have been calculated averaging the normalized changes calculated
for each individual cell. The effects of drug (e.g., 53-THPROG and
THIP) upon the pooled normalized frequency of action currents relative
to the control were analyzed statistically using a one-way repeated mea-
sure ANOVA with post hoc testing. Specifically, the mean percentage
change in action current firing was calculated for each 90 s bin through-
out the recording for every cell tested and then averaged. The effects of
53-THPROG andTHIP upon the spontaneous firing were then quan-
tified after 10 and 4 min, respectively.
Preparation of lysates andWestern blotting
Hypothalamic and cerebellum samples were dissected fromwhole brains
and PVN punches were obtained from hypothalamic slices (900 m
thick) prepared as described above. In each instance, samples were im-
mediately placed in ice-cold lysis buffer containing the following (in
mM): 500NaCl, 250NaF, 125 TrisHCl, 50NaPPi, 25 EGTA, 5 EDTA, and
1 Na3VO4, along with 0.1% (v/v) mercaptoethanol, 1% Triton X-100
(v/v), and 86 mg ml1 sucrose. The tissue was homogenized on ice and
centrifuged for 10 min at 12,000 rpm at 4°C. The resulting supernatant
was collected and the pellet discarded. The protein content of the lysate
was determined by the method of Bradford (1976). Proteins of interest
(10 g) were separated by SDS-PAGE and transferred to nitrocellulose
membranes. The membranes were subsequently incubated for 1 h at
room temperature in blocking buffer (5% nonfat dried milk in TBST 20
mMTrisHCl, 150mMNaCl, 0.5%Tween, pH7.4). After this,membranes
were incubated in a phosphospecific antibody targeted to theN-terminal
domain of the GABAAR -subunit (1:500; Millipore) overnight at 4°C
with gentle shaking. Themembranes were washed 5 times with 1TBST
and incubated with horseradish peroxidase-conjugated goat anti-rabbit
IgG (1:5000) for 1 h at room temperature. Subsequently, themembranes
were washed with 1 TBST and incubated with a monoclonal anti
-actin antibody (1:5000; Sigma) for 2 h at room temperaturewith gentle
shaking,which acted as an internal loading control. After furtherwashing
with 1 TBST, the membranes were again incubated with horseradish
peroxidase-conjugated goat anti-rabbit IgG (1:5000) for 1 h at room
temperature and thenwashed oncemore. Total protein was visualized by
enhanced chemiluminescence detection (GE Healthcare).
Immunohistochemistry
Visualization of biocytin-filled cells
To confirm that the recorded cells were CRFve, biocytin (0.1%) was
added to the intracellular electrolyte. Immunohistochemistry for biocy-
tin was performed according to previous protocols (Swinny et al., 2010).
Tissue preparation
Anaesthesia was induced with isoflurane and maintained with urethane
(1.25 mg/kg bodyweight, i.p.). The animals were perfused transcardially
with 0.9% saline solution for 3 min, followed by 15 min fixation with a
fixative consisting of 1% paraformaldehyde and 15% v/v saturated picric
acid in 0.1 M phosphate buffer (PB), pH 7.4. This weak fixation protocol
allows for the visualization of somatic CRFwithout the need for pretreat-
ing animals with colchicine. The weak fixation also allows for the visual-
ization of integral membrane proteins such as NMDA subunits. The
brains were kept in the same fixative solution overnight at 4°C. Coronal
sections of the PVN, 50 m thick, were prepared on a Vibratome and
stored in 0.1 M PB containing 0.05% sodium azide.
4
(Figure legend continued.) pan-neuronal marker used to delineate the PVN. F2, F6, Over-
views demonstrating the increase in vGLUT2 immunoreactivity throughout the PVN and lateral
hypothalamus in tissue from ELS mice. Magnified views of the PVN demonstrating the relative
increase in vGLUT2 (F3,F7) and vGLUT2-CRF (F4,F8) expression in ELS tissue. Quantification of
vGLUT2 clusters within the PVN revealed a significant increase in ELS tissue ( p 0.001 WT vs
ELS, unpaired Student’s t test). CRF immunoreactivity in ELS tissue was significantly greater
than that detected in CTRL tissue ( p	 0.001, unpaired Student’s t test). Scale bars, 100m.
Note that tissue fromCTRLandELSWTmicewas reactedand imagedunder identical conditions.
Scale bars: F1, F2, F5, F6, 100m; F3, F7, 10m; F4, F8, 10m.
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Immunohistochemical reaction
Nonspecific binding of secondary antibodies was blocked by incubating
sections with 20% normal horse serum dissolved in Tris-buffered saline
containing 0.3% Triton X-100 (TBS-Tx) for 2 h at room temperature.
The following primary antibodies were used: guinea pig anti CRF (1:
2000; Bachem); rabbit anti-excitatory amino acid transporter 1 (EAAT1,
1:250; Abcam); rabbit anti GABAAR -subunit (1:500, a gift fromWerner
Sieghart); mouse anti-glial fibrillary acid protein (GFAP, 1:2000; Neuro-
mab); mouse anti-HuC (1:500; Invitrogen); rabbit anti-vGLUT2 (1:
1000; Synaptic Systems); mouse anti-vGLUT2 (1:4000; Neuromab;
mouse anti-GluN1 (1:1000; Neuromab); andmouse anti-GluN2B (Neu-
romab). The primary antibodies were diluted in TBS-Tx overnight at
4°C. After washing with TBS-Tx, sections were incubated in a mixture of
appropriate secondary antibodies conjugated with Alexa Fluor 488
(Invitrogen), indocarbocyanine (Cy3; Jackson ImmunoResearch),
and indodicarbocyanine (Cy5; Jackson ImmunoResearch) for 2 h at
room temperature. Sections were washed in TBS-Tx and mounted in
Vectashield (Vector Laboratories). Method specificity was also tested
by omitting the primary antibodies in the incubation sequence. To
confirm the absence of crossreactivity between IgGs in double- and
triple-immunolabeling experiments, some sections were processed
through the same immunocytochemical sequence, except that only an
individual primary antibody was applied with the full complement of
secondary antibodies.
Image acquisition
Sections were examined with a confocal laser-scanning microscope
(LSM710; Zeiss) using either a PlanApochromatic 63DICoil objective
(numerical aperture [NA] 1.4) or a Plan Apochromatic 100 DIC oil
objective (NA 1.46). Z-stacks were used for routine evaluation of the
labeling. All images presented represent a single optical section. These
images were acquired using sequential acquisition of the different chan-
nels to avoid cross talk between fluorophores, with the pinholes adjusted
to one airy unit for all channels. Images were processed with Zen 2008
Light Edition software (Zeiss) and exported intoAdobe Photoshop.Only
brightness and contrast were adjusted for the whole frame and no part of
a frame was enhanced or modified in any way.
Quantification of vGLUT2, CRF, GFAP, EAAT1, GLUN1, and
GLUN2B immunoreactivity in the PVN of CTRL and ELS WT
mice and 0/0 and WT mice
All sections were processed and imaged under identical conditions and
analyses were performed blind. vGLUT2, GLUN1, and GLUN2B immu-
noreactivity presented as distinct, individual puncta. We therefore were
able to quantify the density of expression, expressed as the number of
individual puncta per 10m2 for vGLUT2 and puncta per 1000m2 for
GLUN. In contrast to the individual or discrete punctate immunoreac-
tivity pattern of vGLUT2, CRF immunoreactivity pattern within the
PVN presented as a combination of signal located within somata and
axonal varicosities. To estimate changes in the levels of CRF within both
somata and axonal varicosities, which would infer total CRF content of
the PVN, we quantified the fluorescence intensity in control and ELS
tissue. Similarly, because GFAP signal is not located in astrocytic cell
bodies, fluorescence intensity was also used to estimate the relative levels
of GFAP and EAAT1 expression. The imaging and quantification was
performed as follows: within a tissue section, 3 fields of view (FOVs)were
selected within the PVN. Z-stacks consisting of 3 optical sections spaced
5 m apart in the Z-plane were acquired for each FOV. The dimensions
of each optical sectionwere 85m 85m 1m in theX-Y-Z planes.
Within an optical section, the number of vGLUT2 puncta was manually
counted or the fluorescence intensity for CRF, GFAP, and EAAT1 was
measured using ImageJ software. A value for each FOV was obtained by
computing the average from the optical sections containedwithin a FOV.
The degree of background labeling for individual experiments was deter-
mined in tissue sections reacted with only the secondary antibodies.
Background fluorescence was then subtracted from the values obtained
for individual markers. The means 
 SD (vGLUT2 in puncta/10 m2;
GLUN1 and GLUN2B in puncta per 1000 m2; or CRF, GFAP, or
EAAT1 fluorescence intensity in arbitrary units) for all FOV between
sections and between either control or ELS animals was compared for
statistical differences using Kruskal–Wallis one-way ANOVA. These val-
ues were then pooled because there were no statistical differences (p 
0.05) between the values for FOV between sections and between animals.
All quantitative immunohistochemical data were thus derived from
three FOVs per tissue section, three tissue sections per animal (except for
GLUN1 and GLUN2B immunoreactivity analysis in WT control, when
two tissue sections per animal were used), three control and three ELS
animals (all from six distinct litters). The average value from all FOVs
and sections per animal were computed for individual animals. This
average value for an individual animal was then considered an n of 1.
Results
Validation of a mouse ELS model
To investigate the impact of ELS on mouse hypothalamic neu-
rotransmitter function and neurosteroid modulation, we ad-
Table 1. Summary of the properties of excitatory and inhibitory phasic currents and extrasynaptic currents recorded frommpd neurons of WT CTRL, WT ELS, and0/0 mice
Excitatory and inhibitory phasic currents
WT CTRL WT ELS 0/0
mEPSC (n 15) sEPSC (n 32) mEPSC (n 14) sEPSC (n 26) mEPSC (n 16) sEPSC (n 32)
Peak amplitude (pA) 32
 3 26
 1 32
 2 30
 2† 31
 2 28
 1
Rise time (ms) 0.3
 0.1 0.3
 0.1 0.3
 0.1 0.3
 0.1 0.3
 0.1 0.4
 0.1
W (ms) 1.6
 0.2 1.5
 0.1 1.5
 0.1 1.7
 0.1 1.7
 0.2 1.6
 0.1
Frequency (Hz) 1.9
 0.3 2.5
 0.3 5
 1.5† 4
 0.5† 2.3
 0.5 6.1
 1*††
mIPSC (n 9) sIPSC (n 25) mIPSC (n 11) sIPSC (n 18) mIPSC (n 11) sIPSC (n 18)
Peak amplitude (pA) 60
 2 49
 3 41
 3† 45
 5 54
 5 49
 3
Rise time (ms) 0.4
 0.1 0.6
 0.1 0.5
 0.1 0.5
 0.1 0.4
 0.1 0.5
 0.1
W (ms) 6.8
 0.6 7.7
 0.4 7.1
 0.5 6.7
 0.5 6.8
 0.4 7.4
 0.5
Frequency (Hz) 1.7
 0.7 2.1
 0.4 2.4
 0.9 3.8
 0.8 1.9
 0.7 2.7
 0.5
Extrasynaptic currents
WT CTRL WT ELS 0/0
IKynurenic acid (pA) 18
 5 37
 6‡ 40
 5‡‡
IAP-5 (pA) 11
 7 28
 5 30
 10
ITFB-TBOA (pA) 55
 6 24
 8‡‡ 32
 5‡
ITHIP (pA) 18
 3 - 15
 5
*p	 0.05, **p	 0.01 unpaired Student’s t test mEPSC versus sEPSC for0/0 neurons. †p	 0.05, ††p	 0.01 unpaired Student’s t testWT ELS or0/0 versusWT CTRL. Note that recordings weremade using low intracellular Cl (12mM;
see SI) so that EPSCs and IPSCs could be recorded from the same cell at a holding potential of63 and 0 mV, respectively.
‡p	 0.05, ‡‡p	 0.01 WT ELS or 0/0 versus WT CTRL (WT CTRL, n 6–12; WT ELS, n 4–7; 0/0, n 4–17). Drug concentrations used: kynurenic acid 2 mM, AP-5 50M, TFB-TBOA 200 nM, and THIP 1M.
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opted a model of fragmented maternal care, as described
previously (Rice et al., 2008 and see Materials and Methods).
Confirming the validity of the model and in agreement with Rice
et al. (2008), dams from the ELS group more frequently left the
nest (i.e., exhibited an increased number of sorties) compared
with controls (F(1,52) 10.9, p	 0.01, two-way ANOVA, n 7
litters for each group; Fig. 1A), whereas the total duration of the
dam–pup interactions did not differ between the ELS and control
groups (effect of day: F(5,52) 0.26, p 0.93; effect of treatment:
F(1,52) 1.04, p 0.31, two-way ANOVA; Fig. 1B). In agreement
with abnormal maternal care, the ELS pup weight was signifi-
cantly reduced at P9, at weaning, and at
adult age comparedwith CTRL (p	 0.01,
unpaired Student’s t test; Fig. 1C). More-
over, CRF somatic immunoreactivity in
the PVN of ELS-exposed neonatal mice
(P22–P28) was significantly greater than
that detected in control tissue (fluores-
cence intensity in arbitrary units for con-
trol: 16.13 
 0.07; for ELS: 24.67 
 0.05;
n  3 for both; p 	 0.001, unpaired Stu-
dent’s t test; Fig. 1D) and the upregulation
was maintained through to adulthood
(2 months; control: 21.06 
 0.04; ELS:
26.74 
 0.09; n  3 for both; p  0.001,
unpaired Student’s t test). Collectively,
these data show that the ELS paradigm
used in this study results in enduringmet-
abolic and neurochemical changes that
appear to manifest as a consequence of
impoverished maternal care in early life.
ELS enhances glutamatergic drive onto
neonatal mpd neurons and impairs
astrocytic glutamate reuptake
As a prelude to investigating the actions of
ELSonneurotransmitter functionof thehy-
pothalamic stress neurocircuitry, identifica-
tion of distinct parvocellular neuronal
populations was achieved initially using a
combination of anatomical, electrophysio-
logical, and immunohistochemical criteria,
as described in detail in the Materials and
Methods. Our analysis suggests that similar
anatomical and electrophysiological criteria
to those previously applied to rat hypotha-
lamic slices (Luther et al., 2002; Melnick et
al., 2007) can be used to characterizemouse
parvocellular neurons. Specifically, mouse
parvocellular neurons located in the mpd
anddp/mpv regionswere confirmed to cor-
respond to the neuroendocrine CRF-
releasing (LTSve) and preautonomic
(LTS-expressing, LTSve) neurons respec-
tively (Luther et al., 2002; Fig. 2A). Addi-
tional confirmation that the recorded cells
wereCRFvewas obtainedbypost hoc im-
munohistochemical analysis of biocytin-
filled cells (Fig. 2B).
An altered glutamatergic drive in the
PVN has previously been inferred from
molecular studies in rodent models of
chronic stress (Flak et al., 2009; Miklo´s
and Kova´cs, 2012). Therefore, we investigated whether ELS al-
tered the balance of excitatory (Boudaba et al., 1997; Herman et
al., 2002; Ulrich-Lai et al., 2011) to inhibitory drive (Zaki and
Barrett-Jolley, 2002; Biancardi et al., 2010) onto mpd neurons.
Miniature and spontaneous EPSCs (mediated by glutamate) and
IPSCs (mediated byGABA)were recorded from the same neuron
by adjusting the holding potential to EGABA (63 mV) and
EGlutamate (0 mV), respectively (see Materials and Methods). The
frequency of the mIPSCs was similar for the control and ELS
groups (p  0.05, unpaired Student’s t test) whereas the ampli-
Figure3. Exposure to ELSgreatly increasesmpdneuronglutamatergic conductanceand impairs astrocytic glutamate reuptake.
A, Boxplot showing themean IGlutamate recorded frommpdneuronsderived fromcontrol (CTRL;white) andELS (red)WTmiceupon
thebath applicationof kynurenic acid (2mM).Note that themean IGlutamate is greater for ELSmpdneurons comparedwith CTRLWT.
p	 0.05, unpaired Student’s t test (CTRL, n 12; ELS, n 7). B, Bar graph illustrating the mean TFB-TBOA (200 nM)-induced
current recorded from CTRL (black) and ELS (red)WTmpd neurons. *p	 0.05 CTRL vs ELS, unpaired Student’s t test (CTRL, n 6;
ELS, n 7). C, Representative whole-cell voltage-clamp recordings of mpd neurons derived from CTRL (black) and ELS (red) WT
mice under control conditions after the bath application of TFB-TBOA (200nM) and in the combinedpresence of TFB-TBOA (200nM)
and kynurenic acid (2 mM). The TFB-TBOA-induced current was reversed in both cases by the subsequent bath application of
kynurenic acid (2mM). Note that the tonic IGlutamate after kynurenic applicationwas significantly greater for the ELS comparedwith
CTRLWTneuron. The representative tracesweregeneratedbyaveraging themeanDCof 100msepochs every2 swithpoints falling
on to the decay of sEPSCs or those containing spurious noise being discarded from the analysis. The dotted line represents the
holding current before drug application. Scale bars: y 50 pA, x 100 s. D, Immunolocalization of the astrocytic cytoskeleton
protein GFAP and the glial-specific glutamate transporter EAAT1 demonstrating their relative levels of expression in the PVN of
tissue from control and ELSmice reacted and imaged under identical conditions. Low-power overview examination indicated that
the distribution of GFAP-immunoreactive profiles throughout the PVNwas not noticeably different in tissue from control (D1) and
ELS (D4) mice. However, high resolution inspection of GFAP immunoreactive arbours revealed those in control tissue (D3) to be
noticeably thicker compared with those in ELS tissue (D6), suggesting ELS-induced structural plasticity of astrocytes. The levels of
EAAT1 immunoreactivity are consistently higher in control (D2,D3) compared with ELS (D5,D6) tissue in accordance with the
functional data above. Scale bars: D1, D2, D4, D5, 100m; D3, D6, 10m.
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Figure 4. Exposure to ELS blunts 53-THPROG suppression of mpd neuron firing and alters Cl homeostasis in these neurons. A, Left, Summary graph depicting the time course of the effect
(expressedaspercentageof the control frequency) of 53-THPROG (100nM)upon the frequencyof action currents recorded fromcontrol (CTRL; black,n8) andELS (red,n6)WTmpdneurons.
Right: Bar graph summarizing the effect of 100 nM 53-THPROGupon the spontaneous firing ofWT CTRL (black, n 8), ELS (red, n 6)mpd, and CTRL dp/mpvneurons (gray, n 3). *p	 0.05
one-way RMA vs control; †p	 0.001 ELS vs CTRLWTmpd neurons, two-way RMA.B, Sections (10 s) of cell-attached recordings obtained from representative CTRL and ELSWTmpd neurons before
and 10 min after the bath application of 100 nM 53-THPROG. Scale bars: y 20 pA, x 2 s. C, Cumulative probability plots of the decay of all mIPSCs (described by T70 values) collected from
steroid-sensitive CTRL (left, n 8) and ELS (right, n 5) WT mpd neurons before (CTRL: black, ELS: red) and after (gray) the bath application of 100 nM 53-THPROG. The insets illustrate the
superimposed normalized ensemble averages of mIPSCs recorded from representative CTRL (left) and ELS (right) WTmpd neurons before and after the bath application of 100 nM 53-THPROG.
Scale bars: y20pA, x10ms.D, Paired plots of theWvalue before and after treatmentwith 100nM53-THPROG for each CTRL (left; black) and ELS (right; red)WTneuron tested. ELS neurons
deemed neurosteroid insensitive (T70, p 0.01, KS test) are shown in gray. C, control; NS, in the presence of neurosteroid. E, Bar graph illustrating the impact of 53-THPROG (100 nM) upon the
sEPSC (neurosteroid-sensitive) and sIPSC frequency for CTRL (black,n 6–7) and ELS (red,n 4–5)WTmpdneurons. *p	 0.05 vs control; p 0.05 CTRL vs ELSWT, two-wayRMA. F, I–V curves
of the GABA-evoked response (normalized to themaximumoutward current for each individual cell) derived fromperforated-patch recordings for CTRL (black, n 7) and ELS (red, n 7)WTmpd
neurons. Note the rightward shift in the EGABA for mpd neurons derived from ELS mice. The insets illustrate representative current traces recorded at different holding potentials from CTRL (black)
and ELS (red)mpdneurons. Scale bars: y 20 pA, x 250ms.G, Box plot showing themean EGABA obtained inmpdneurons derived fromCTRL (white, n 7) and ELS (red, n 7)WTmice during
perforated patch recordings. The box extends from the 25 th percentile to the 75 th percentile with the line designating the median value and the point the mean EGABA value. The upward and
downwardbars illustrate theupper and lower limits of the rangeof values.p	0.05CTRL vs ELS, unpaired Student’s t test.H, Bar graph illustrating themeanGABA-driving force (calculatedasVmemb
 EGABA) obtained from perforated patch recording of CTRL (black, n 7) and ELS (red, n 7) WTmpd neurons. *p	 0.05, unpaired Student’s t test.
Table 2. Summary of the spontaneous action current firing properties recorded frommpd neurons of WT CTRL, WT ELS, and0/0 mice
Cells firing spontaneously Cells tonically firing Mean frequency tonically firing cells (Hz)
WT CTRL 69% (327/476 cells) 21% 6.1
 0.5
WT ELS 65% (59/91 cells) 25% 5.1
 0.7
0/0 69% (141/204 cells) 22% 5.7
 0.7
CTRL TBOA (200 nM) LiAc (1–1.5 mM) RO-256981 (100 nM)
WT 6.5
 0.8 7.4
 1.9 — —
ELS 5.1
 0.7 — 5
 0.7 5.9
 0.8
0/0 5.7
 0.7 — 6.6
 0.9 5.5
 0.9
p 0.05 unpaired Student’s t test WT ELS or 0/0 versus WT CTRL mean frequency (WT CTRL, n 92; WT ELS, n 20; 0/0, n 37).
p 0.05 unpaired Student’s t test for each treatment group versus respective control. (WT CTRL, n 10–13; WT ELS, n 12–20; 0/0, n 9–37).
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tude exhibited an30% decrease (p	 0.05, unpaired Student’s
t test; Fig. 2D, Table 1). The ELS sIPSC frequency appeared in-
creased comparedwith control, but only approached significance
(p 0.06, unpaired Student’s t test) with no changes in the sIPSC
amplitude (p 0.05, unpaired Student’s t test; Fig. 2C,D, Table
1). In contrast, the frequency of sEPSCs was significantly in-
creased for ELS compared with control mpd neurons (p	 0.05,
unpaired Student’s t test; Fig. 2C,E, Table 1). Note that no differ-
ence in the frequency of sEPSCs was observed between male or
female mice bred under control conditions (male: 2.7
 0.5 Hz,
n 16; female: 2.4
 0.3Hz,n 16, p 0.47, unpaired Student’s
t test) or for those exposed to ELS (male: 4.2 
 0.6 Hz, n  13;
female: 3.9
 0.8 Hz, n 13, p 0.75, unpaired Student’s t test),
so the data were pooled. In the presence of TTX, the mEPSC
frequency for ELS mpd neurons was similarly increased com-
pared with the WT (p	 0.05, unpaired Student’s t test; Fig. 2E,
Table 1). In addition, the amplitude of the sEPSCs, but not mEP-
SCs, appeared modestly increased (p	 0.05, unpaired Student’s
t test; Table 1). In agreement with the altered function, immuno-
histochemistry of the PVN revealed a significant increase in the
expression of the vesicular glutamate transporter vGLUT2, a se-
lective marker of presynaptic glutamatergic input, in ELS com-
paredwith control (vGLUT2 clusters per 10m2; control: 1.53

0.08; ELS: 2.44
 0.09; n 3 animals for both; p	 0.05, unpaired
Student’s t test; Fig. 2F). Next, we explored possible additional
alterations in glutamatergic transmission mediated by extrasyn-
aptic receptors (Groc et al., 2009; Paoletti et al., 2013). The tonic
glutamatergic conductance, revealed by the magnitude of the
current induced by kynurenic acid (2mM), for ELSmpd neurons
was significantly greater than control (p 	 0.05, unpaired Stu-
dent’s t test; Fig. 3A, Table 1). Note that no difference in the tonic
conductance was observed between male or female mice bred
under control conditions (male: 20 
 7 pA, n  6; female:
17 
 9 pA, n  6; p  0.84, unpaired Student’s t test) or
exposed to ELS (male:35
 11 pA, n 3; female:34
 7 pA,
n 4; p 0.71, unpaired Student’s t test) conditions, so the data
were pooled. Regardless of magnitude, for both control and ELS
neurons, this current was primarily mediated by tonic activation
of NMDA receptors (NMDARs); that is, the percentage of the
current induced by 2mM kyneurenic acid that was AP-5 sensitive
(control: 73 
 39, n  6; ELS: 80 
 10, n  4; p  0.05 ELS vs
CTRL, one-way repeated-measure ANOVA [RMA]). In contrast,
no resident GABAAR-mediated tonic current was detected in
control or ELS neurons (bicuculline 30M-evoked current: con-
trol: 4.4
 2.8 pA, n 7; ELS: 3.6
 2.4 pA, n 4). Impaired glial
glutamate transporter function has been implicated in glutama-
tergic dysfunction (Oliet et al., 2001; Fleming et al., 2011; Tasker
et al., 2012; Go´mez-Gala´n et al., 2013). The transporter inhibitor
TFB-TBOA (200 nM; Shimamoto et al., 2004) produced an in-
ward, kynurenic acid-sensitive current that was significantly
greater for control neurons compared with the ELS group (p 	
0.05, unpaired Student’s t test; Fig. 3B,C, Table 1). In accordance
with the functional data above, the level of immunoreactivity
(mean 
 SD, arbitrary units) for the EAAT1 was significantly
lower in the PVN of tissue obtained from ELS mice compared
with control (control: 69 
 2 vs ELS: 59 
 2, n  3 animals for
both; p  0.004, unpaired Student’s t test; Fig. 3D). Low-power
overview examination of the immunoreactivity pattern for
GFAP, the cytoskeleton protein found in astrocytes, revealed no
apparent differences in the distribution of the signal throughout
the PVN of control and ELS mice (Fig. 3D1,D4). This suggests
that the number of astrocytesmay not be significantly different in
control andELSmice. This could not be confirmed quantitatively
because the GFAP signal is not located in astrocytic cell bodies.
However, high-resolution quantification of the intensity of
GFAP immunoreactivity revealed it to be significantly lower in
the PVNof tissue obtained fromELSmice comparedwith control
(control: 5.5
 0.4 vs ELS, 2.3
 0.2, n 3 animals for both; p
0.001, unpaired Student’s t test; Fig. 3D3,D6). Furthermore, at
the high-resolution visualization, GFAP-immunoreactive arbors
were noticeably thinner in ELS compared with control sections,
an ELS-induced alteration in astrocyte morphology that likely
results in the altered levels of EAAT1 expression. The changes in
the EAAT1 and GFAP expression patterns suggest a combined
structural and neurochemical remodeling of astrocytes as a result
of ELS. These findings are consistent with an impaired glial glu-
tamate transporter function in the PVN of ELS mice (Fleming et
al., 2011). Together, our observations suggest that ELS alters the
ratio of excitatory to inhibitory inputs onto neonatal (P18–P26)
mpd neurons in favor of the former, primarily as a consequence
of a considerably greater glutamate-mediated excitatory drive.
ELS indirectly compromises inhibitory transmission: a role
for GABAAR-active neurosteroids?
Although the ELS experience appeared to affect modestly
GABAAR-mediated inhibitory transmission compared with
glutamate-mediated excitatory transmission, additional inhibi-
tory mechanisms may fail. It is well established that certain en-
Table 3. Summary of the properties of mIPSCs and the effect of 53-THPROG uponmIPSC properties & RMS recorded frommpd neurons of WT CTRL, WT ELS, and0/0 mice
WT CTRL WT ELS 0/0
Peak amplitude (pA) 116
 17 80
 10* 136
 11
Rise time (ms) 0.4
 0.1 0.4
 0.1 0.4
 0.1
W (ms) 6.4
 0.2 6.0
 0.4 6.8
 0.3
T70 (ms) 8.4
 0.5 7.4
 0.6 8.8
 0.5
Control 100 nM Control 100 nM Control 100 nM
Peak amplitude (pA) 150
 17 139
 15 83
 6 89
 9 116
 19 115
 21
Rise time (ms) 0.4
 0.1 0.4
 0.1 0.4
 0.1 0.4
 0.1 0.4
 0.1 0.4
 0.1
W (ms) 7.0
 0.3 10.1
 0.9†† 5.9
 0.8 8.0
 1.6† 7.9
 1.2 11.1
 1.3†
T70 (ms) 8.9
 0.4 13.3
 1.1†† 7.7
 1.2 9.7
 1.3† 10.0
 1.2 15.8
 1.9††
RMS (pA) 0.56
 0.2 0.13
 0.1 0.63
 0.2
*p	 0.05 unpaired Student’s t test WT ELS or 0/0 versus WT CTRL (WT CTRL, n 29; WT ELS, n 17; 0/0, n 19).
†p	 0.05 paired Student’s t test, ††p	 0.01 paired Student’s t test (WT CTRL, n 8; WT ELS, n 7; 0/0, n 5).
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Figure 5. Inhibition of mpd neuronal firing by 53-THPROG can be partially restored in ELS neurons or attenuated in WT neurons by decreasing or increasing the glutamatergic tone,
respectively. A, Bar graph illustrating the relative frequency (expressed as percentage control) of sIPSCs and sEPSCs recorded from ELS (n 16 and 20, respectively) mpd neurons preincubated in
1–1.5mM LiAc for 1–2 h before recording. *p	 0.05 control vs LiAc, one-way RMA for ELS.B, Bar graph illustrating themean kynurenic acid (2mM)-induced IGlutamate recorded from control (CTRL;
black, n 12), ELS (red, n 7), and RO-256981(100 nM)-treated ELS (red hatched, n 6) mpd neurons. *p	 0.05 RO-256981-treated ELS vs untreated control; †p	 0.05 vs CTRL, one-way
ANOVA;p0.05CTRL vsRO-256981-treated ELS, one-wayANOVA.C, Bar graph summarizing the effect of 53-THPROG (100nM) upon the frequency of action currents recorded fromCTRL (black,
n 8), ELS (red, n 6), LiAc-treated (white, n 4), and RO-256981-treated (red hatched, n 5) ELSmpd neurons. Note that 53-THPROG caused a significant reduction in the action current
frequency of ELS neurons preincubatedwith LiAc (1–1.5mM) or RO-256981 (100 nM) comparedwith their untreated controls. *p	 0.05 LiAc-treated or RO256981-treated ELS vs untreated control;
†p	 0.01 vsWT, two-way RMA.D, Sections (10 s) of cell-attached recordings obtained from representative LiAc-treated (left) and RO-256981-treated ELS (right) mpd neurons before and 10min
after the bath application of 100 nM 53-THPROG. Scale bars: y 20 pA, x 2 s. E, NMDA receptor subunit expression in the neonatal PVN. E1, GluN1 subunit signal appears as distinct clusters
throughout the PVN and are closely apposed to vGLUT2 clusters. Quantification of the density of GluN1-immunoreactive clusters revealed that of the 23
 1 clusters per 1000m2 (mean
 SD),
20
 1 clusters per 1000m2 (90%)were apposed to vGLUT2 immunoreactive clusters (n 3). E4, Magnified view of the boxed area in E3. E5, Intense GluN2B signal throughout the PVN that
appears to be located to a lesser extent in the proximity of vGLUT2. Quantification of the density of GluN2B-immunoreactive clusters revealed that, of the 21
 1 clusters (Figure legend continues.)
19544 • J. Neurosci., December 11, 2013 • 33(50):19534–19554 Gunn et al. • Neurosteroids and Early Life Stress
dogenously occurring neurosteroids (e.g., 53-THPROG)
potently and selectively enhance GABAAR function at low nano-
molar concentrations (Belelli and Lambert, 2005). Intriguingly,
neurosteroid levels change dynamically in response to stress chal-
lenges (Purdy et al., 1991; Barbaccia et al., 1996; Biggio et al.,
2007) and therefore may “fine-tune” GABAAR function of PVN
neurons to influence HPA axis activity. Therefore, we explored
how ELS may influence the actions of 53-THPROG upon the
frequency of truncated action currents recorded from spontane-
ously, tonically firing mpd neurons of the neonatal hypothala-
mus (P18–P26), as described previously (Perkins, 2006; Yang et
al., 2007). For WT control,2/3 of all mouse parvocellular neu-
rons tested exhibited spontaneous action current firing (Table 2).
Such activity was completely abolished by the ionotropic gluta-
mate receptor antagonist (2 mM) kynurenic acid (n 3; data not
shown) and their frequency was increased by the GABAAR antag-
onist bicuculline (30M; 254
 56%of control, n 10; p	 0.05,
one-way RMA). Similar to spinally projecting parvocellular neu-
rons (Womack et al., 2006), the action current frequency of con-
trol mpd neurons was decreased by physiological concentrations
of 53-THPROG (10 and 100 nM) to 60
 7% (5 of 8 cells) and
24
 3% of control (8 of 8 cells), respectively (p	 0.01 for both
concentrations, one-way RMA; Fig. 4A,B, left), an effect that was
reversed by bicuculline (data not shown). No differences in the
effect of 100 nM 53-THPROGwere observed between neurons
derived from either male (21
 6% of control, n 4) or female
(34
 7% of control, n 4) mice, so the data were pooled (p
0.24 two-way RMA). Moreover, dp/mpv neurons were similarly
sensitive to 53-THPROG 100 nM (p  0.05, two-way RMA;
Fig. 4A, right). We subsequently focused on the CRFve mpd
neurons. For these neurons, the experience of fragmented dam–
pup interactions (i.e., ELS behavioral paradigm) severely com-
promised the potent inhibitory actions of the neurosteroid.
Therefore, although the frequency of action currents was similar
for control and ELSWT neurons (Table 2), in ELSmpd neurons,
53-THPROG (100 nM) was ineffective (p 0.05 vs ELS con-
trol, but p 	 0.01 for ELS vs WT control, two-way RMA; Fig.
4A,B). Note that, similar to the control, no difference in the effect
of 100 nM 53-THPROG was observed upon neurons derived
from male (89
 5% of control, n 3) or female (98
 13% of
control, n  3) ELS mice, so the data were pooled (p  0.55,
two-way RMA).
The neurosteroid insensitivity observedmay result from ELS-
induced changes in excitatory or inhibitory transmission. Given
that GABAARs are the specific target of neurosteroid actions
(Belelli and Lambert, 2005), we initially investigatedwhether ELS
altered the interaction of neurosteroids with synaptic GABAARs
(e.g., their prolongation of the mIPSC decay; Cooper et al., 1999;
Belelli and Lambert, 2005). The sensitivity of mpd neuron
GABAARs to neurosteroid action was assessed individually for
each cell in paired recordings using equal intra- and extracellular
Cl concentrations (see Materials and Methods). In agreement
with the recordings with low intracellular Cl described above
(ELS enhances glutamatergic drive onto mpd neurons and im-
pairs astrocytic glutamte reuptake; Fig. 2, Table 1), ELS caused a
significant decrease ( 30%) of the mIPSC amplitude compared
with control neurons, but had no significant impact on their rise
time or decay kinetics (Table 3). 53-THPROG (100 nM) did
not affect RMS noise, mIPSC peak amplitude, or rise time in
either group (Table 3), but prolonged the mIPSC decay of both
control and ELS mpd neurons (% w increase, control: 43 
 9,
n 8; ELS: 34
 10, n 7; p	 0.001, one-wayRMAvs respective
control for both groups, but p  0.05 for WT control vs ELS;
two-way RMA). Analysis of the individual cell sensitivity (p 	
0.01 KS test for T70 values, see Materials and Methods) revealed
that all control cells (n 8) and 70% (5 of 7 tested) from the ELS
group were sensitive to the neurosteroid (Fig. 4C,D). However,
given that the action current discharge of all ELS neurons was
insensitive to 53-THPROG (100 nM), changes to the neuro-
steroid sensitivity of synaptic GABAARs of the ELS group do not
account for the loss of steroid efficacy. We investigated next
whether a putativeGABAAR-mediated presynaptic steroid action
(Poisbeau et al., 1997; Haage and Johansson, 1999; Uchida et al.,
2002; Ruiz et al., 2010) influenced network-driven transmission
(i.e., sIPSC and sEPSC frequency) and if it was affected by the ELS
experience. For control neurons, 53-THPROG (100 nM) de-
creased the sEPSC frequency to 70
 3%of control in 7 of 10 cells
tested (p 	 0.001 vs control, one-way RMA; Fig. 4E), an action
likely to contribute to the neurosteroid-evoked suppression of
mpd neuronal firing (Fig. 5A andDiscussion). In contrast, 53-
THPROG (100 nM) had no effect upon the sIPSC frequency (p
0.05 vs control, one-way RMA; Fig. 4E). However, importantly,
the action of 53-THPROG upon sEPSC frequency (mediated
by presynaptic GABAARs) and the lack of effect of the steroid
upon the sIPSC frequency were not influenced by the ELS expe-
rience (p  0.05 control vs ELS WT, two-way RMA for both
sIPSC and sEPSC neurosteroid effects; Fig. 4E), thus suggesting
that the potent GABAAR-mediated inhibitory presynaptic ac-
tions upon the frequency of glutamatergic events were unaltered.
An alteration of Cl homeostasis to convert the actions of GABA
from inhibitory to excitatory could contribute to the ELS-
induced impairment of 53-THPROG actions on neuronal fir-
ing (Hewitt et al., 2009). Gramicidin-perforated patch recordings
revealed that EGABA was significantly more depolarized for ELS
compared with control (p	 0.05, unpaired Student’s t test; Fig.
4F,G), but VMembrane was unaffected (p  0.05, unpaired Stu-
dent’s t test; Table 4). Therefore, the driving force was signifi-
cantly reduced compared with control, but remained
hyperpolarizing for the ELS group (p	 0.05, unpaired Student’s
t test; Fig. 4H, Table 4).
4
(Figure legend continued.) per 1000 m2 (mean
 SD), 15
 1 clusters per 1000 m2
(70%)were apposed to vGLUT2-immunoreactive clusters (n 3). E8, Magnified viewof the
boxed area in E7. Scale bars: E1–E3, E5–E7, 10m; E4, E8, 1m. F, Left, Bar graph illustrat-
ing themean firing frequency ofWTmpd neurons before (black) and after the bath application
of TFB-TBOA (200 nM, white, n 5), p 0.05, paired Student’s t test. Right, Sections (10 s) of
cell-attached recordings obtained from a representativeWTmpd neuron before (top) and after
(bottom) the bath application of TFB-TBOA. Scale bars: y  10 pA, x  2 s. G, Bar graph
summarizing the effect of 53-THPROG (100 nM) upon the frequency of action currents re-
corded from controlWT (black, n 8), TBOA-treatedWT (black hatched, n 6), and ELS (red,
n 6) mpd neurons. Note that 53-THPROG induced a significant reduction in the action
current frequency only in WT neurons. †p	 0.001 vs WT, two-way RMA. H, Sections (10 s) of
cell-attached recordings obtained from representative control (left) and TBOA-treated WT
(right) mpd neurons before and 10 min after the bath application of 100 nM 53-THPROG.
Scale bars: y 10 pA, x 2 s.
Table 4. Summary of the perforated patch recordingmeasurements for mpd
neurons of WT CTRL, WT ELS, and0/0 mice
WT CTRL WT ELS 0/0
Resting Vmembrane (mV) 63
 3 61
 2 57
 4
EGABA (mV) 79
 4 67
 3* 78
 3
GABA driving force (Vmemb EGABA ) (mV) 16
 4 6
 3* 21
 5
RInput (M) 1643
 222 1442
 349 1452
 210
*p	 0.05 unpaired Student’s t test versus WT CTRL (WT CTRL, n 7; WT ELS, n 7; 0/0, n 5)
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Figure 6.  0/0 mice exhibit blunted neurosteroid actions upon mpd firing, reduced body weight neonatally, elevated CRF expression, and increased vulnerability to ELS exposure. A, Summary
graph depicting the time course of the effect of 53-THPROG (100 nM) upon the frequency of action currents recorded frommpd neurons ofWT (black, n 8) and 0/0 (blue, n 7)mice.B, Bar
graph summarizing the effect of 53-THPROG (100 nM) upon the frequency of action currents recorded frommpd neurons derived fromWT (black) and  0/0 (blue) mice. *p	 0.01 vs control,
one-way RMA. C, Sections (10 s) of cell-attached recordings obtained from representative WT and  0/0 mpd neurons before and 10 min after the bath application of 100 nM 53-THPROG. Scale
bars: y20pA, x2 s.D, Bar graphs summarizing themeanweights of CTRLWT (black) and 0/0 (blue) at P9, P18–P24, and8weeks of age (WT,n26–31; 0/0,n24–36). Note thatweight
was significantly lower at P9 for 0/0 vsWT *p	 0.05, unpaired Student’s t test. E, Left: Graph summarizing themean number of sorties from the nest for control (black, n 5) and 0/0 (blue, n
5)WT dams from P3–P8. Therewas no significant effect of genotype (F(1,47) 0.001, p 0.97) or day (F(5,47) 1.27, p 0.29) on the number ofmaternal sorties. Right: Graph summarizing the
mean dam–pup interaction time over P3–P8 for the same litters as above. Therewas no effect of day (F(5,47) 0.73, p 0.61) or genotype (F(1,47) 3.2, p 0.08) upon the time spent in the nest
(two-way ANOVA). F, Representative images of CRF expression in the PVN of WT and  0/0 neonatal (P22–P28) mice using immunohistochemistry. F1, F3, HuC (a pan-neuronal marker) was used
to confirm that the regions investigated are comparable.F2, CRF immunoreactivitywithinWT tissue is expressedwithin somata and varicose processes.F4, ComparedwithWT tissue, CRF expression
within the PVN of  0/0 mice is increased significantly and more widely distributed throughout the PVN ( p 0.001, unpaired Student’s t test). Tissue sections were reacted and imaged under
identical conditions. Scale bar, 100m.G, Bar graph illustrating the total number ofmaternal sorties for controlWT (black) and 0/0 (blue)mice and those housed under ELS (red) conditions. There
was only a main effect of treatment upon the number of sorties. *p	 0.001 ELS vs respective CTRL, either WT or  0/0, two-way ANOVA (for details, see Table 5). (Figure legend continues.)
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Does the increased glutamatergic drive contribute to the
impaired neurosteroid actions uponmpd firing?
The findings described above indicate for mpd neurons amodest
decrease inGABAAR-mediated inhibition (i.e., lowermIPSC am-
plitude and a reduced hyperpolarizing driving force), but also
suggest that altered GABAAR properties and/or their neuroste-
roid sensitivity cannot account for the blunted neurosteroid ac-
tion upon action potential discharge. Therefore, we next
considered whether the loss of neurosteroid efficacy may be an
indirect consequence of the increased excitatory drive, which
would neutralize neurosteroid inhibition (Prescott et al., 2006).
We first investigated whether reducing either the synaptic or
tonic excitatory drive to ELS mpd neurons to levels comparable
to WT could rescue the inhibitory action of 53-THPROG
upon neuronal firing. The vGLUT2 inhibitor lithium acetoace-
tate (LiAc) reduced the synaptic drive (Juge et al., 2010), with a
30% decrease in the sEPSC frequency for ELSmpd neurons (p	
0.05, control vs LiAc, one-way RMA; Fig. 5A). This treatment
partially restored 53-THPROG inhibition of ELS (Fig. 5C,D,
left) mpd neuronal firing (p 	 0.05 for LiAc-treated ELS vs re-
spective untreated control and p	 0.01 vs WT, two-way RMA).
Similarly, RO-256981 (100 nM), a selective antagonist of
GLUN2B-containing receptors (which are abundantly expressed
extrasynaptically in mpd neurons; Fig. 5E5–E8), reduced the
tonic current of ELS to a level comparable to WT mpd neurons
(p 0.05WT vs RO-256981-treated ELS, one-way ANOVA; Fig.
5B). Similar to LiAc, this treatment partially rescued the inhibi-
tion of mpd discharge by 100 nM 53-THPROG for ELS (p 	
0.05 both for RO-256981-treated ELS vs respective controls and
vs WT, two-way RMA; Fig. 5C,D, right). Note that the firing
frequency of ELSmpd neurons was unaffected by treatment with
either LiAc or RO-256981 (Table 2). To further corroborate the
proposal that increased glutamatergic drive suppresses the inhib-
itory action of 53-THPROG onmpd neuronal firing, the neu-
rosteroid action on mpd firing was tested in WT slices treated
with TFB-TBOA (200 nM). In common with ELS, in paired re-
cordings, the bath application of TFB-TBOA did not affect the
firing frequency of WT mpd neurons (p  0.05, WT vs WT 
TFB-TBOA, paired Student’s t test; Fig. 5F), presumably because
of a ceiling for the frequency of tonically firing mpd neurons.
However, and consistent with the above proposal, the actions of
53-THPROG (100 nM) were similarly blunted for TFB-
TBOA-treated mpd neurons (Fig. 5G,H). These findings with
treatments to reduce or enhance glutamatergic transmission are
consistent with the proposal that the increased excitatory drive
contributes significantly to the loss of the neurosteroid action in
the ELS PVN.
0/0 mice exhibit some phenotypic signatures common to
ELS mice
Interestingly, 0/0 mice suffer from impaired maternal care
(Maguire and Mody, 2008) and, in common with ELS, exhibit
blunted actions by another GABAAR-active neurosteroid, 5,3
tetrahydrodeoxycorticosterone (i.e., 53-THDOC), upon neu-
ronal firing of CRFve neurons (Sarkar et al., 2011). In agree-
ment, we found that 100 nM 53-THPROG was ineffective
upon cell firing of 0/0mpdneurons (p 0.05 vs own control but
p	 0.05WTvs 0/0, two-wayRMA; Fig. 6A–C).Nodifferences in
the effect of 100 nM 53-THPROGwere observed between neu-
rons derived from male (99
 10% of control, n 4) or female
(96 
 4% of control, n  3) 0/0 mice, so the data were pooled
(p 0.79, two-way RMA).
In view of the apparent similarities shared by the ELS and 0/0
models, we first investigated the maternal behavior of 0/0 dams
and the ensuing effect on the offspring. In commonwithWTELS
mice, the 0/0 pup weight was significantly reduced at P9 com-
pared with WT (p	 0.05 unpaired Student’s t test), but reached
levels comparable to control mice at weaning and adult age (p
0.05, unpaired Student’s t test; Fig. 6D). However, the number of
maternal sorties of 0/0 dams was not significantly different com-
pared with WT dams (F(1,47)  0.001, p  0.97, two-way
ANOVA;n 5 litters for both genotypes; Fig. 6E, left), suggesting
the maternal behavior of 0/0 to be distinct from WT ELS dams
(Kaffmann and Meaney, 2007). Further, as for WT ELS, the du-
ration of the dam–pup interactions was not different from the
WT control (F(1,47)  3.2, p  0.08, two-way ANOVA; n  5
litters for both genotypes; Fig. 6E, right). Importantly, and in
common with WT ELS mice, 0/0 mice exhibited a significant
increase of CRF immunoreactivity in the soma of mpd neurons
(fluorescence intensity in arbitrary units: WT tissue: 10.7
 0.3;
0/0 tissue: 13.53 
 0.2; n  3 animals for both, p  0.001,
unpaired Student’s t test; Fig. 6F). The increased CRF expression
in 0/0 mpd neurons suggested a potential susceptibility of the
0/0mouse strain to stressful challenges. To corroborate this pro-
posal, we explored the impact of ELS on 0/0 mouse breeding.
Consistent with our hypothesis, the ELS paradigm resulted in a
significantly more severe phenotype cf. WT ELS. In common
with the influence of ELS on WT mice, there was a significant
effect of ELS exposure upon the number of 0/0 maternal sorties
(F(1,20) 20.3, p	 0.001, two-wayANOVA; Fig. 6G), although
the effect of ELS exposure on this parameter was not influenced
4
(Figure legend continued.) H, Bar graphs summarizing the mean weights of control WT
(black) and 0/0 (blue)mice and those housed under ELS (red) conditions at P9, P18–P24, and
8 weeks of age (WT: CTRL, n 36–42; ELS, n 35–63;  0/0: CTRL, n 24–36; ELS, n
12–24). At P9 and P18–P24, there was a significant effect of both genotype and treatment,
whereas at8 weeks, only a main effect of treatment was observed (two-way ANOVA; for
details, see Table 5). However, note mortality rate below. At P9, the mean weight of control
 0/0 pups is significantly reduced compared with WT. ‡p	 0.05. In addition, at all ages, the
mean weight of bothWT and 0/0 pups exposed to ELS is significantly reduced compared with
their respective controls. *p	 0.001. Importantly, the mean weight of  0/0 mice exposed to
ELS is significantly lower than that of WT ELS mice both at P9 and P18–P24 (†p	 0.05), but
was not different at 8weeks of age ( p 0.05). For details, see Table 5. I, Plot summarizing the
mean percentage deaths per litter for WT and  0/0 animals housed under control (WT, black;
 0/0, blue) and ELS (red both for WT and  0/0) conditions at P9, P24, and 8 weeks of age. The
mortality rate of control WT and  0/0 pups did not significantly change with age ( p 0.05,
one-way RMA). In contrast, the mortality rate of WT and  0/0 pups exposed to ELS increased
with age ( p	 0.05, one-way RMA) andwas dramaticallymore pronounced for 0/0 compared
with WT ELS (slope of 17.3 vs 1.9, respectively). III, Third ventricle.
Table 5. Summary of statistical analysis of ELS treatment upon the sorties and
weight of WT and0/0 mice
Sorties (n) Weight
F-value p-value F-value p-value
Effect of genotype (G)
P9 F(1,20) 2.7 0.116 F(1,161) 49.9 	0.001
P18–P24 — — F(1,128) 6.2 0.014
8 wk — — F(1,103) 1.1 0.293
Effect of treatment (T)
P9 F(1,20) 20.3 	0.001 F(1,161) 161.9 	0.001
P18–P24 — — F(1,128) 49.3 	0.001
8 wk — — F(1,103) 14.7 	0.001
G T interaction
P9 F(1,20) 2.6 0.12 F(1,161) 5.3 0.02
P18–P24 — — F(1,128) 14.1 	0.001
8 wk — — F(1,103) 0.007 0.935
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Figure 7.  0/0 mice display alterations in glutamatergic transmission similar to WT ELS mice, which blunt neurosteroid suppression of mpd neuron firing. A, Illustrated are sections (5 s) of
whole-cell voltage-clamp recordings of sIPSCs (top) and sEPSCs (bottom) obtained from the same representative mpd neurons for WT (left) and  0/0 (right) neonatal (P18–P26) mice. A section
(shaded area, 0.5 s) of the recordings is displayed on an expanded time scale below. Scale bars: IPSCs, y 20 pA; EPSCs y 10 pA; x 500ms and 50ms for top and bottom traces, respectively.
B, Bar graphs illustrating the mean frequency of sEPSCs and mEPSCs (left, n 15–32) and sIPSCs and mIPSCs (right, n 9–25) for mpd neurones derived fromWT (black) and  0/0 (blue) mice.
Note that the frequency of sEPSCs is significantly greater for  0/0 compared with WT CTRL (*p	 0.01, unpaired Student’s t test), whereas the mEPSC, sIPSC and mIPSC frequency are unchanged
( p 0.05, unpaired Student’s t test). C, Representative images of vGLUT2 expression in the PVN of WT and 0/0 mice. The density of vGLUT2 puncta was similar for WT and 0/0 mice ( p 0.05,
unpaired Student’s t test). Scale bar, 10m.D, Box plot showing themean IGlutamate forWT (white, n 12) and
0/0 (blue, n 17)mpdneurons revealed by the bath application of kynurenic acid
(2mM). Note that themean IGlutamate is greater for
0/0mpdneurons comparedwithWT ( p	 0.01 unpaired Student’s t test). E, Bar graph illustrating themean TFB-TBOA (200 nM)-induced current
recorded frommpdneurons derived fromCTRLWT (black) and 0/0 (blue)mice upon the bath application of kynurenic acid (2mM). *p	 0.05 vsWT, unpaired Student’s t test (WT,n 6; 0/0,n
4). F, Bar graph illustrating the relative frequency (expressed as a percentage of control) of sIPSCs and sEPSCs recorded from 0/0 (n 13 and 17 respectively) mpd neurons preincubated in 1–1.5
mM LiAc for 1–2 h before recording. *p	 0.05 control vs LiAc, one-way RMA. G, Bar graph illustrating the mean kynurenic acid (2 mM)-induced IGlutamate recorded fromWT (black, n 12), 
0/0
(blue, n 17), and RO-256981(100 nM)-treated 0/0 (blue hatched, n 4) mpd neurons. *p	 0.05 RO-256981-treated 0/0 vs untreated control; †p	 0.05 vs WT, one-way ANOVA; p 0.05
WTvsRO-256981-treated 0/0, one-wayANOVA.H, Bar graph summarizing the effect of 53-THPROG (100nM) upon the frequency of action currents recorded fromWT (black,n8), 0/0 (blue,
n 7), LiAc-treated (white, n 6), and RO-256981-treated (blue hatched, n 6)  0/0 mpd neurons. Note that 53-THPROG caused a significant reduction in the action current frequency of
 0/0 neurons preincubatedwith LiAc (1–1.5mM) or RO-256981 (100 nM) comparedwith their untreated controls. *p	 0.05 LiAc or RO-256981-treated 0/0 vs untreated control; †p	 0.01 vsWT,
two-way RMA. I, Sections (10 s) of cell-attached recordings obtained from representative LiAc-treated (left) and RO-256981-treated (right)  0/0 mpd neurons before and 10 min after the bath
application of 100 nM 53-THPROG. Scale bars: y 20 pA, x 2 s.
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Figure 8. -GABAARs are not expressed in the PVN. A,B, Overviews (A1–A3) show the characteristic expression pattern of the subunit in tissue from neonatal (P22–P28)WTmouse, which is
not detectable in tissue from 0/0 mice (B1–B3). Magnified views of the PVN ofWT (A4,A5) and 0/0 (B4,B5) mice demonstrate that, even at high resolution, no-subunit signal is detectable in
this brain region comparedwith thalamic ventromedial nucleus (VM). Scale bars: A1–A3,B1–B3, 100m; A4, A5,B4,B5, 10m. C, RepresentativeWestern blot detecting the expression of the
-subunit in homogenates prepared from WT and  0/0 “punches” of mouse brain tissue. A total of 10g of protein was loaded per lane and a clear immunoreactive signal was detected in WT
samples for cerebellum (CB), but not for PVN andhypothalamus (HYP). In addition, note the lack of-signal detected in CB sample derived froma 0/0mouse.-actinwas used as a loading control.
D, Representative whole-cell voltage-clamp recordings (Vh60 mV) from WT (top) and 
0/0 (bottom) mpd neurons under control, after the bath application of THIP (1M), and after the
combinedapplicationof THIP (1M) andbicuculline (30M).Note that THIP (1M) inducedonly a similar,modest inward current inWTand 0/0mpdneurons, aneffect reversedby the subsequent
applicationof bicuculline (30M). Scale bars: y10pA, x100 s. The representative tracesweregeneratedby averaging themeanDCof 100msepochs every 2 swithpoints fallingon to thedecay
ofmIPSCs or containing spurious noise being discarded from the analysis. The dotted line represents the holding current before drug application. E, Summary bar chart illustrating the effect of THIP
(1M) upon the Iholding (expressed as THIP-induced current) of WT (black; n 6) and 
0/0 (blue; n 4) mpd neurons. p 0.05, unpaired Student’s t test. F, Left, Summary graph depicting the
lack of an effect of THIP (1M) upon the action current frequency recorded fromWTmpd neurons (n 7). p 0.05, paired Student’s t test. Right, Summary bar chart illustrating the lack of effect
of THIP (1M) upon the frequency of either sEPSCs or sIPSCs. p 0.05, one-way RMA; n 4 for both measurements. III, Third ventricle.
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by genotype (i.e., there was no significant interaction between
genotype and treatment: F(1,20)  2.6, p  0.12; two-way
ANOVA; for detailed statistics, see Table 5). However, the weight
of the 0/0 ELS pups was significantly lower at both at P9 and
P21–P24 comparedwith the control 0/0,WTcontrol, orWTELS
experimental groups, indicating a significant interaction between
genotype and ELS exposure (P9: F(1,161)  5.3, p 	 0.05; P18–
P24: F(1,128)  14.1, p 	 0.001; two-way ANOVA; for detailed
statistics, see Table 5; Fig. 6H). Most significantly, although the
0/0 ELS pup weight was comparable to WT ELS by their adult
stage, ELS breeding resulted in an increasedmortality rate for 0/0
mice from P9 to adulthood compared with 0/0 control and WT
ELS mice (Fig. 6I).
Given the apparent similarity of the molecular phenotypes of
the stress axis (i.e., increased CRF expression) and the shared
neurosteroid insensitivity of mpd neuron firing exhibited byWT
ELS and 0/0 mice, we investigated whether they also shared the
same functional plasticity (i.e., increased glutamatergic drive). In
common with WT ELS, neonatal 0/0 mpd neurons also exhib-
ited a significantly greater frequency of sEPSCs (p 	 0.05, un-
paired Student’s t test; Fig. 7A,B, left), but an unaltered sIPSC
frequency (p  0.05, unpaired Student’s t test; Fig. 7A,B, right,
Table 1). Note that no differences were observed in the frequency
of sEPSCs between the sexes (male: 5 
 1.5 Hz, n  13; female:
6.8 
 1.3 Hz, n  19, p  0.4, unpaired Student’s t test). How-
ever, in contrast to WT ELS mpd neurons, the 0/0 mEPSC fre-
quency was unaltered compared with control WT (p  0.05,
unpaired Student’s t test; Fig. 7B, left). In agreement with this,
there were no significant differences between vGLUT2 labeling
for 0/0 compared with WT mpd neurons (vGLUT2 clusters per
10 m2 WT: 1.48 
 0.03; 0/0: 1.60 
 0.05; n  3 animals for
both; p  0.05, unpaired Student’s t test; Fig. 7C). As described
for mpd neurons from WT ELS mice, the frequency of mIPSCs
was similar forWT and 0/0 mice (p 0.05, unpaired Student’s t
test; Fig. 7B, right). Moreover, in common with WT ELS, 0/0
mpd neurons exhibited an enhanced glutamatergic tonic con-
ductance (p	 0.01, unpaired Student’s t test. Fig. 7D, Table 1),
which was largely mediated by NMDARs (AP-5-sensitive com-
ponent: 66
 10%, n 4; p 0.05 vs WT control and WT ELS,
one-way RMA) and themagnitude of this current did not exhibit
any differences between the sexes (male: 42 
 9 pA, n  8;
female:38
 5 pA, n 9, p 0.69 unpaired Student’s t test).
Furthermore, the transporter inhibitor TFB-TBOA (200 nM)
produced an inward, kynurenic acid-sensitive current that was
significantly reduced compared with WT (p 	 0.05, unpaired
Student’s t test; Fig. 7E, Table 1). Importantly, and in common
with ELS, treatment with either LiAc to produce a 25% reduction
in sEPSCs frequency (Fig. 7F) or RO-256981 (100 nM) to reduce
theNMDAR-mediated tonic current of 0/0 to values comparable
to WT mpd neurons (p  0.05 WT vs RO-256981-treated 0/0,
one-way ANOVA; Fig. 7G) partially restored 53-THPROG
inhibition of 0/0 mpd neuronal firing (p	 0.05 for LiAc-treated
0/0 vs respective untreated control and p	 0.01 vsWT, two-way
RMA; p	 0.05 for RO-256981-treated 0/0 vs respective controls
and vs WT, two-way RMA; Fig. 7H, I). Note that, in common
with ELS, the firing frequency of 0/0 mpd neurons was also unaf-
fected by treatment with either LiAc or RO-256981 (Table 2).
Because neurosteroid actions are reported to be greatly influ-
enced by the presence of the -subunit (Mihalek et al., 1999;
Belelli et al., 2002; Brown et al., 2002; Sarkar et al., 2011), the lack
of -GABAARs could conceivably contribute to the impaired ste-
roid effect on mpd neuron firing. However, in agreement with
previous studies (Wisden et al., 1992; Fritschy andMohler, 1995;
Ho¨rtnagl et al., 2013 but see Sarkar et al., 2011), we found no
immunohistochemical or molecular evidence for -subunit ex-
pression or labeling in either neonatal (P22–P28; Fig. 8A–C) or
adult ( 2 months; data not shown) mpd neurons. In support of
this finding, whole-cell voltage-clamp recordings revealed that
the -GABAAR-preferring agonist THIP (1 M) only induced a
modest bicuculline-sensitive inward current that was similar for
both WT and 0/0 neonatal (P18–P26) mpd neurons (p  0.05
0/0 vs WT, two-way ANOVA; Fig. 8D,E), presumably reflecting
the limited activation of other (e.g., 52 or 	-containing) re-
ceptor isoforms in both the WT and 0/0 strains (Ranna et al.,
2006; Sto´rustovu and Ebert, 2006). Furthermore, for WT neu-
rons, THIP (1 M), in clear contrast to the neurosteroid, had no
effect upon the frequency of action currents, mIPSCs, or the
frequency of sEPSCs (p 0.05, one-way RMA; Fig. 8F, Table 6).
Impairment of neurosteroid actions on 0/0 mpd neuronal dis-
charge may nevertheless implicate an alteration in the properties
and/or sensitivity of inhibitory currents to neurosteroids (Vicini
et al., 2002). However, neither the properties of mIPSCs (p 
0.05, unpaired Student’s t test) nor the neurosteroid sensitivity of
GABAAR-mediated mIPSCs (p  0.05 WT vs 
0/0, two-way
RMA) nor the presynaptic actions of the neurosteroid on the
frequency of sEPSCs (reduction) and sIPSCs (no effect) for 0/0
mpd neuronswere significantly different fromWT (p 0.05WT
vs 0/0, two-way RMA for both measurements; Fig. 9A–C, Table
3). Furthermore, in contrast to WT ELS neurons, perforated
patch recordings did not reveal any difference in EGABA or
VMembrane, and thus the driving force, between 
0/0 andWTmpd
neurons (p  0.05, unpaired Student’s t test for all 3 measure-
ments; Fig. 9D–F, Table 4).
In summary, our findings offer compelling evidence that ad-
verse early-life experiences are associated with a dramatic up-
regulation of excitatory transmission within stress-activated
neuronal circuits, leading to a failure of inhibitory mechanisms,
one of which we show to be dependent on GABAAR-active, en-
dogenously occurring steroids.
Discussion
The impact of early-life experiences on neuronal development is
well documented and adverse events are known to program an
abnormal stress response by encoding long-lasting molecular
changes in the brain (Heim et al., 2010). Such adaptations in turn
have a negative impact onmental health and cognitive abilities in
both humans and animals (Lupien et al., 2009). The specific neu-
robiological mechanisms underpinning the detrimental and per-
sistent effects of early-life adversity are not fully elucidated, but
they are recognized to operate on a background of genetic sus-
ceptibility (i.e., genetic diathesis stress theory; Heim et al., 2010).
Here, we offer an insight into such mechanisms by providing
functional and molecular evidence for a novel form of hypotha-
lamic neuronal plasticity in an environmentally-induced (ELS)
mouse and a genetic mouse model (0/0) of ELS. Although there
Table 6. Summary of the effect of THIP (1M) upon the properties of mIPSCs
recorded fromWTmpd neurons
WT
Control THIP
Peak amplitude (pA) 157
 12 177
 17
Rise time (ms) 0.4
 0.1 0.4
 0.1
W (ms) 6.8
 0.8 7.3
 0.8
Frequency (Hz) 1.1
 0.4 1.0
 0.4
p 0.05 paired Student’s t test (n 5).
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are clear differences in the nature of thematernal care, bothmod-
els exhibited a significantly increased synaptic and extrasynaptic
glutamatergic drive impinging upon CRFvempd neurons. The
increased excitatory drive produces a dramatic loss of the potent
inhibitory actions of the stress-protective, GABAAR-active neu-
rosteroid 53-THPROG on the firing of CRFve neurons.
Abnormal maternal care alters the hypothalamic
excitatory/inhibitory balance
Environmental stress alters glutamatergic transmission in corti-
cal/limbic areas via an increase in glutamate release and/or dys-
function of glial and synaptic transmission (de Vasconcellos-
Bittencourt et al., 2011; Sanacora et al., 2012). In the
hypothalamus, increased somatic excitatory drive for mpd neu-
rons was indirectly inferred for rodent models of chronic stress
(Flak et al., 2009; Miklo´s and Kova´cs, 2012), whereas a reverse
adaptation (i.e., a decrease) was associated with a model of aug-
mented maternal care (Korosi et al., 2010). The present study
provides for the first time direct functional evidence that ELS
causes an upregulation of the synaptic glutamatergic drive in the
stress centers of the neonatal hypothalamus and reveals a novel
role for a tonic, NMDAR-mediated extrasynaptic conductance.
Furthermore, pertinent to the genetic diathesis stress theory, this
molecular signature is shared by 0/0 mice, which display some
phenotypic features suggestive of abnormal maternal care (albeit
clearly distinct from ELS mice). Furthermore, in common with
ELS mice, the 0/0 mice exhibited an upregulated somatic CRF
expression in mpd neurons. These findings apparently contrast
with those of Rice et al. (2008) regarding decreased CRF mRNA,
but may be accounted for by the lower rate of mRNA transcrip-
tion compared with protein translation in mammals (Vogel and
Marcotte, 2012); that is, mRNA levels may not accurately reflect
changes in peptide levels. Consistent with a stress-susceptible
phenotype, when the ELS paradigm was imposed upon 0/0
mouse breeding, the pups exhibited an exaggerated responsewith
an increased perinatal and adult mortality rate compared with
WT ELS or 0/0 controls. This increased susceptibility of the 0/0
mice to the breeding conditions may contribute to the more se-
vere behavioral phenotype described for 0/0 mice (Maguire and
Mody, 2008). However, cross-fostering experiments are required
to establish the relative contribution of genetic andmaternal care
abnormalities (Priebe et al., 2005) to the described 0/0 pheno-
type (present study andMaguire andMody, 2008). Nevertheless,
our findings raise the prospect that polymorphisms of the GA-
BRD gene may underlie an increased susceptibility to stressful
experiences and, therefore, to the development of psychopathol-
ogy in humans (Feng et al., 2010).
Although some changes in neural inhibition were induced by
ELS (reduced mIPSC amplitude and hyperpolarizing GABA-
ergic driving force), these were not evident for the 0/0 mouse.
Importantly, we demonstrated that the deficit in 53-THPROG
efficacy for both ELS and 0/0 mice is not caused by the neuroste-
roid being less effective as a GABAAR modulator, but in both
cases, appears to be a consequence of the increased glutamatergic
drive. In support of this, drugs that enhanced (in WT) or inhib-
ited (in both ELS and 0/0 mice) glutamatergic transmission
blunted or facilitated, respectively, the effect of the neurosteroid
on AP discharge in the PVN. These findings indicate that the
increased excitatory drive in 0/0 mice is sufficient to negate the
steroid inhibitory actions upon neuronal firing by converting it
from probabilistic to deterministic (Prescott et al., 2006). Never-
theless, it cannot be excluded that additional changes in GABAA,
Figure 9. Deletion of the-subunit does not alter the neurosteroid sensitivity of synaptic GABAARs or the polarity of the GABA-evoked response of mpd neurons. A, Cumulative probability plots
of the decay of all mIPSCs (expressed as T70 values) collected fromWT (right, n 8) and 0/0 (left, n 5) mpd neurons before (WT: black, 0/0: blue) and after (gray) the bath application of 100
nM 53-THPROG. The insets illustrate the superimposed normalized ensemble averages of mIPSCs recorded from representative mpd neurons before and after the bath application of 100 nM
53-THPROG. Scale bars: y 20 pA, x 10ms, applicable to both traces. B, Paired plots of the W value before and after treatment with 100 nM 53-THPROG for WT (right, black) and
0/0
(left, blue)mpdneurons tested. Note that all neuronswere deemedneurosteroid sensitive (T70, p	 0.01 KS test). C, Control; NS, in the presence of neurosteroid. C, Bar graph illustrating the impact
of 53-THPROG (100 nM) upon the sEPSC (neurosteroid-sensitive) and sIPSC frequency forWT (black, n 6–7) and 0/0 (blue, n 4–6)mpd neurons. *p	 0.05 vs CTRL, one-way RMA; p
0.05WTvs 0/0, two-wayRMA.D, I–V curves of theGABA-evoked response (normalized to themaximumcurrent obtained for each cell) derived fromperforated-patch recordings forWT (black,n
7) and 0/0 (blue,n 5)mpdneurons. Each point represents themean
 SEM ( p 0.05, unpaired Student’s t test). The insets illustrate representative current traces obtained at different holding
potentials for WT (black) and 0/0 (blue) mpd neurons. Scale bars: WT, y 20 pA, x 250ms; 0/0, y 10 pA, x 250ms. E, Box plot showing themean EGABA obtained for WT (white, n 7)
and 0/0 (blue, n 5)mpd neurons subject to perforated patch recordings ( p 0.05 unpaired Student’s t testWT vs 0/0; for details, see Table 4). F, Bar graph illustrating themean GABA-driving
force (calculated as Vmemb EGABA) for WT (black, n 7) and 
0/0 (blue, n 5) mpd neurons ( p 0.05 unpaired Student’s t test; for details, see Table 3).
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glutamate receptor expression/function, or, indeed, additional
proteins in other stress-responsive regions of the hypothalamus
or telencephalon contribute to the ELS or 0/0 phenotype. For
example, permanent alterations in hippocampal GABAAR func-
tion and expression after early-life adversity have been described
previously (Hsu et al., 2003).
Molecular targets of neurosteroid action and relevance to
their stress-protective effects
Although the blunted neurosteroid action in the 0/0 mouse ap-
pears to agree with a potent direct interaction of neurosteroids
with recombinant -GABAARs (Belelli et al., 2002; Brown et al.,
2002), our molecular, immunohistochemical, and functional
(the -preferring agonist THIP) analysis is consistent with the
lack of expression of -GABAAR in the hypothalamus reported
previously (Wisden et al., 1992; Fritschy andMohler, 1995; Ho¨rt-
nagl et al., 2013), albeit apparently inconsistent with the report by
Sarkar et al. (2011). The reasons for the discrepancy are not evi-
dent, although the use of different mouse lines may be a contrib-
uting factor. Here, we speculate that the potent inhibitory action
of the neurosteroid on neuronal discharge is mediated by 2-
GABAARs expressed by mpd neurons and/or by those “up-
stream” in the PVN circuitry; for example, those located on
glutamatergic terminals. Interestingly, the development of a hy-
peractive HPA axis during the neonatal period is associated with
an anxious and depressive adult phenotype when a genetically
engineered 2-GABAAR deficit is introduced embryonically, but
not in the fourth postnatal week (Shen et al., 2010). Whether
neurosteroids contribute to this phenotype is unknown.
Inhibition of mpd firing by physiological concentrations of
53-THPROG may be relevant to the documented anxiolytic
and stress-protective actions of neurosteroids (Patchev et al.,
1994, 1996; Biggio et al., 2007; Gunn et al., 2011). Specifically,
with regard to the impact of early-life events, modulation of
GABAARs by neurosteroids during neonatal development may be
important for normalmaturation of the HPA axis, thus influencing
the excitability of stress-responsive PVN neurons (Korosi and
Baram,2009) inamanner similar to thatdescribedpreviously for the
prefrontal cortex (Grobin et al., 2003). Providing indirect support
for this, neonatal administration of the GABAAR-active neuroste-
roid 5,3-THDOC (at P2–P12) counteracts the neuroendocrine
and behavioral dysregulation of the HPA axis evident in adult rats
subjected as neonates to maternal separation (Patchev et al., 1997).
Therefore, impaired neonatal neurosteroid signaling may contrib-
ute to HPA dysfunction and associated mood disorders (Pariante
and Lightman, 2008).
Programming of the stress response and the incidence of
mental disorders: relevance of the increased glutamatergic
drive in the hypothalamus
This report reveals for the first time a novel role for increased gluta-
matergicNMDAR-mediated conductance inmpdneuron hyperex-
citability of both neonatal (P18–P26) ELS and 0/0mice, specifically
highlighting a dysfunction of the astrocytic glutamate transporters.
Becauseanaberrant stress responseassociateswithdepressionand in
agreement, normalizationof theHPAaxis is oneof themajor targets
of antidepressant treatment (Schu¨le et al., 2009), these findingsareof
specific significance in the quest for uncovering the biological basis
of mental disorders for two reasons. First, they inform on a specific
molecularmechanismwhereby adverse early-life events programan
abnormal development of the neuronal stress circuit. Second, and
importantly, they add to a growing body of evidence that endorses
important roles for both environmental stress and increased gluta-
matergic transmission as a consequence of astrocytic dysfunction in
the pathophysiology of depression (Sanacora et al., 2012; Go´mez-
Gala´n et al., 2013). Furthermore, they provide support for the pro-
posal that ionotropic glutamate receptors represent a novel
therapeutic target for the treatment of stress-related psychiatric dis-
turbances such as depression. Indeed, in agreement with animal
studies (Li et al., 2011), recent clinical investigations with NMDAR
antagonists, including GluN2B-receptor-selective ligands, have re-
ported promising results in trials of treatment-resistant major de-
pressive subjects (Preskorn et al., 2008; Li et., 2011; Ibrahim et al.,
2012; Sanacora et al., 2012; Zarate et al., 2013). A detailed character-
ization of the behavioral profile of adult ELS compared with 0/0
mice provides scope for future studies. Although our analysis indi-
cates no sex differences in the hypothalamic glutamatergic altera-
tions of 3- to 4-week-old mice experiencing early-life stress, it
remains to be determined whether both sexes will be similarly af-
fected in adulthood given the documented sex differences in the
incidence of psychiatric disorders.
At present, we do not know whether a specific relationship
exists between ELS-induced upregulation of glutamatergic trans-
mission and neurosteroid production within the PVN or telen-
cephalic regions. However, NMDARs are implicated in the
endogenous synthesis of neurosteroids inCA1hippocampal neu-
rons (Tokuda et al., 2011; Zorumski et al., 2013). The present
study raises the prospect that a similar scenario may apply to the
neonatal PVN, where the neurosteroid enzymatic machinery is
expressed abundantly (Eechaute et al., 1999). Moreover, a novel
form of regulation of the excitatatory-inhibitory balance involv-
ing cross talk between NMDA and GABAA receptors in preauto-
nomic parvocellular neurons has been reported (Potapenko et al.,
2013). Future studies will explore the relationship and possible
interdependence of early-life dysfunction of the stress neurocir-
cuitry, NMDAR activity, neurosteroid synthesis, and behavior.
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